Drug Database · Clinicians

Rosuvastatin

Brands (234) Roswin, Rosalta, Rosucol…Show all
Roswin · Rosalta · Rosucol · Aurora · Varostin · Chaletin · Crestor · Rostar · Rosucoa · Rosuvel · Zyrova · Crestat · Lipidbloc · Registatin · RosuSave · Rosuu · Rovastin · Rovista · Rozugen · Rozzu · Ruchol · Suvastin · Arterix · Athero · Delteria · Dismigras · Gorovast-20 · Ldnil · Lipidar · Lipiruvin · Lowas · Revasc · Robestar · Rosett · Rostad · Rosucass · Rosucura · Rosucure · Rosumond · Rosunav · Rosuphil · Rosustat · Rosutech · Rosuvapro · Rosuvasure · Rosuvaz · Rosuvin 10 · Rosvascal · Rozatin-10 · Rozatin-20 · Rozatin-40 · Rozatin-5 · Roztat · Rozutor · Rustor · Sorvaztin · Stator · Tobistatin · Torros · Vasitra · Zenrosu · Amvast · Arteon · Arvast 10 · Arvast 20 · Aztin · Better Rozz 10 · Better Rozz 20 · BEZTIN · Cardiostin-10 · Caroza 40 · Cholefast · Cholestrovas · Cholsuvin · Colestrovas · Controld 20 · Cosuvast · Crestar · Crestin · Crestodix-10 · Crestodix-20 · Cresvid 20 · Fadztat · Fusovast · Glenraz 10 · Glenraz 40 · Glenraz 5 · Gorovast 40 · Gorovast-10 · Goroztin-10 · Gostatin 20 · Jiaavast-10 · Jiaavast-20 · Jivastatin · Kingstat 10 · Kingstat 20 · Kingstat 40 · Kingstat 5 · Lipicore · Lipiguard-10 · Lipiguard-20 · Lipvast 40 · Lowas 10 · Lustatin-40 · Lustatin-5 · Mayrosu · One-Rosu 20 · Pausolip-20 · Prehart · Presuvas · Rainsuvast · Reestatin · Rhosa · Rofast 10 · Rofast 20 · Rofast 40 · Rosadoc-10 · Rosadoc-20 · Roschlotin · Rosett 20 · Rosgen · Rosin 40 · Roslem · Rospec · Rosrich · Rost 20 · Rostan · Rostatin-20 · Rostin 20 · Rosubest-10 · Rosubest-20 · Rosubet-10 · Rosubet-20 · Rosubet-40 · Rosubolic-10 · Rosucare · Rosuche · Rosucres-10 · Rosucres-20 · Rosudaise 10 · Rosudaise 20 · Rosudex · Rosufar-20 · Rosufed-20 · Rosufer · Rosufirst · Rosugold-10 · Rosugold-20 · Rosugrand-10 · Rosugrand-20 · Rosukon · Rosukon-10 · Rosukon-20 · Rosulip-10 · Rosulip-20 · Rosulip-40 · Rosumax-10 · Rosumax-20 · Rosunis · Rosunovtin-20 · Rosuphili 20 · Rosuple 10 · Rosuple 5 · Rosuppex · Rosusaph-10 · Rosusaph-20 · Rosusaph-40 · Rosustan · Rosustat®10 · Rosustat®20 · Rosutera · Rosuvalife 10 · Rosuvalife 20 · Rosuvate-20 · Rosuvax · Rosuvazet 10 · Rosuvazt-10 · Rosuvin 20 · Rosuvra · Rosuxl 20 · Rosuzan · Rosuzan-10 · Rosva 10 · Rosva 20 · Rosva 40 · Rosva 5 · Rosvastium · Rosvera · Rotserc · Rovas 10 · Rovast · Rovastatin 40 · Rovasu 20 · Rovecol · Rovex 10 · Rovex 20 · Rovicor · Roxunov 10 · Roxunov 20 · Roxunov 40 · Roztin-10 · ROZTIN-20 · Rozuhil-10 · Rozuhil-20 · Rozusan-10 · Rozusan-20 · Rozuvas 10 · Ruvastin-10 · Ruvastin-5 · Searosu · Stachol 20 · Stapharm · Statovex · Strator · Stravas · Stravas 10 · Suvast-20 · Torus-10 · Torus-20 · Triastin · Trisovan · Turbovas -10 · TURBOVAS -5 · Turbovas-20 · Vasticure-10 · Vasticure-20 · Vastoril 10 · Vastoril 20 · Vastros-20 · Vazcare · Vestflo-10 · Vestflo-20 · Wilovast · X-Plended

HMG CoA reductase inhibitort; Lipid modifying agent (HMG CoA reductase inhibitor); and others PH FDA category

Rx · Prescription drug386 PH productsPNF-listedPhilHealth GAMOTVAT-exempt (some products)
Dispensing: Prescription (Rx) Last updated: Audience: Licensed health professionals
Label text on this page: US FDA-approved label via DailyMed/openFDA, set ID 325a5d0e-9a72-4015-9fcd-1655fb504cee, version date September 23, 2026 (Crestor · AstraZeneca Pharmaceuticals LP). Reproduced verbatim. Philippine-approved indications and doses may differ: check the PH package insert.

Use: Labeled indications

  • As an adjunct to diet for the treatment of adults with: ∘ Primary dysbetalipoproteinemia. ∘ Hypertriglyceridemia.
US FDA label
Full indications and usage US FDA label

1 INDICATIONS AND USAGE CRESTOR is indicated:

  • To reduce the risk of major adverse cardiovascular (CV) events (CV death, nonfatal myocardial infarction, nonfatal stroke, or an arterial revascularization procedure) in adults at increased risk for these events.
  • As an adjunct to diet and exercise to reduce low-density lipoprotein cholesterol (LDL-C): ∘ in adults with hypercholesterolemia. ∘ and slow the progression of atherosclerosis in adults. ∘ in adults and pediatric patients aged 8 years and older with heterozygous familial hypercholesterolemia (HeFH). ∘ in adults and pediatric patients aged 7 years and older with homozygous familial hypercholesterolemia (HoFH).
  • As an adjunct to diet for the treatment of adults with: ∘ Primary dysbetalipoproteinemia. ∘ Hypertriglyceridemia. CRESTOR is an HMG Co‑A reductase inhibitor (statin) indicated: (1)
  • To reduce the risk of major adverse cardiovascular (CV) events (CV death, nonfatal myocardial infarction, nonfatal stroke, or an arterial revascularization procedure) in adults at increased risk for these events.
  • As an adjunct to diet and exercise to reduce low-density lipoprotein cholesterol (LDL-C): ∘ in adults with primary hypercholesterolemia. ∘ and slow the progression of atherosclerosis in adults. ∘ in adults and pediatric patients aged 8 years and older with heterozygous familial hypercholesterolemia (HeFH). ∘ in adults and pediatric patients aged 7 years and older with homozygous familial hypercholesterolemia (HoFH).
  • As an adjunct to diet for the treatment of adults with: ∘ Primary dysbetalipoproteinemia. ∘ Hypertriglyceridemia.

Contraindications

4 CONTRAINDICATIONS CRESTOR is contraindicated in patients with: • Acute liver failure or decompensated cirrhosis [see Warnings and Precautions (5.3)]. • Hypersensitivity to rosuvastatin or any excipients in CRESTOR. Hypersensitivity reactions including rash, pruritus, urticaria, and angioedema have been reported with CRESTOR [see Adverse Reactions (6.1)]. Acute liver failure or decompensated cirrhosis. (4) Hypersensitivity to rosuvastatin or any excipients in CRESTOR. (4)

US FDA label

Dosing: Adult

Dosage and administration (US label) US FDA label
  • Take orally with or without food, at any time of day. (2.1)
  • Assess LDL-C when clinically appropriate, as early as 4 weeks after initiating CRESTOR, and adjust dosage if necessary. (2.1)
  • Adults: Recommended dosage range is 5 to 40 mg once daily. (2.2)
  • Pediatric Patients with HeFH: Recommended dosage range is 5 to 10 mg once daily for patients aged 8 to less than 10 years of age, and 5 to 20 mg once daily for patients aged 10 years and older. (2.3)
  • Pediatric Patients with HoFH: Recommended dosage is 20 mg once daily for patients aged 7 years and older. (2.3)
  • Asian Patients: Initiate at 5 mg once daily. Consider risks and benefits of treatment if not adequately controlled at dosages up to 20 mg once daily. (2.4)
  • Patients with Severe Renal Impairment (not on hemodialysis): Initiate at 5 mg once daily; do not exceed 10 mg once daily. (2.5)
  • See full prescribing information for CRESTOR dosage and administration modifications due to drug interactions. (2.6)
2.1 General Dosage and Administration Information

2.1 General Dosage and Administration Information

  • Administer CRESTOR orally as a single dose at any time of day, with or without food. Swallow the tablets whole.
  • Assess LDL-C when clinically appropriate, as early as 4 weeks after initiating CRESTOR, and adjust the dosage if necessary.
  • If a dose is missed, advise patients not to take an extra dose. Resume treatment with the next dose.
  • When taking CRESTOR with an aluminum and magnesium hydroxide combination antacid, administer CRESTOR at least 2 hours before the antacid [see Drug Interactions (7.2)].
2.2 Recommended Dosage in Adult Patients

2.2 Recommended Dosage in Adult Patients

  • The dosage range for CRESTOR is 5 to 40 mg orally once daily.
  • The recommended dosage of CRESTOR depends on a patient’s indication for usage, LDL-C, and individual risk for CV events.
2.3 Recommended Dosage in Pediatric Patients

2.3 Recommended Dosage in Pediatric Patients Dosage in Pediatric Patients 8 Years of Age and Older with HeFH The recommended dosage range is 5 mg to 10 mg orally once daily in patients aged 8 years to less than 10 years and 5 mg to 20 mg orally once daily in patients aged 10-years and older. Dosage in Pediatric Patients 7 Years of Age and Older with HoFH The recommended dosage is 20 mg orally once daily.

2.4 Recommended Dosage in Asian Patients

2.4 Recommended Dosage in Asian Patients Initiate CRESTOR at 5 mg orally once daily due to increased rosuvastatin plasma concentrations. Consider the risks and benefits of CRESTOR when treating Asian patients not adequately controlled at dosages up to 20 mg orally once daily [see Warnings and Precautions (5.1), Use in Specific Populations (8.8), and Clinical Pharmacology (12.3)].

2.5 Recommended Dosage in Patients with Renal Impairment

2.5 Recommended Dosage in Patients with Renal Impairment In patients with severe renal impairment (CLcr less than 30 mL/min/1.73 m2) not on hemodialysis, the recommended starting dosage is 5 mg orally once daily and should not exceed 10 mg orally once daily [see Warnings and Precautions (5.1) and Use in Specific Populations (8.6)]. There are no dosage adjustment recommendations for patients with mild and moderate renal impairment.

2.6 Dosage Modifications Due to Drug Interactions

2.6 Dosage Modifications Due to Drug Interactions Table 1 displays dosage modifications for CRESTOR due to drug interactions [see Warnings and Precautions (5.1) and Drug Interactions (7.1)]. Table 1: CRESTOR Dosage Modifications Due to Drug Interactions Concomitantly Used Drug CRESTOR Dosage Modifications Sofosbuvir/velpatasvir/voxilaprevir or Ledipasvir/sofosbuvir Avoid concomitant use.

Gemfibrozil Avoid concomitant use. If use is unavoidable, initiate at 5 mg once daily and do not exceed 10 mg once daily. Tafamidis Avoid concomitant use. If use is unavoidable, initiate at 5 mg once daily and do not exceed 20 mg once daily. Belumosudil Do not exceed 5 mg once daily. Cyclosporine Do not exceed 5 mg once daily.

Darolutamide Do not exceed 5 mg once daily. Vadadustat Do not exceed 5 mg once daily. Additional Antiviral Medications ∘ Simeprevir ∘ Dasabuvir/ombitasvir/paritaprevir/ritonavir ∘ Elbasvir/Grazoprevir ∘ Sofosbuvir/Velpatasvir ∘ Glecaprevir/Pibrentasvir ∘ Atazanavir/Ritonavir ∘ Lopinavir/Ritonavir Initiate at 5 mg once daily.

Do not exceed 10 mg once daily. Capmatinib Do not exceed 10 mg once daily. Enasidenib Do not exceed 10 mg once daily. Momelotinib Do not exceed 10 mg once daily. Regorafenib Do not exceed 10 mg once daily. Teriflunomide Do not exceed 10 mg once daily. Ticagrelor Do not exceed 20 mg once daily. In patients at increased risk for rhabdomyolysis, consider dosages less than 20 mg per day.

Febuxostat Do not exceed 20 mg once daily. Fostamatinib Do not exceed 20 mg once daily.

Dosing: Altered kidney function

From the US FDA label · Renal impairment (dosage and administration, use in specific populations, pharmacokinetics)

2.5 Recommended Dosage in Patients with Renal Impairment In patients with severe renal impairment (CLcr less than 30 mL/min/1.73 m2) not on hemodialysis, the recommended starting dosage is 5 mg orally once daily and should not exceed 10 mg orally once daily [see Warnings and Precautions (5.1) and Use in Specific Populations (8.6)]. There are no dosage adjustment recommendations for patients with mild and moderate renal impairment.

8.6 Renal Impairment Rosuvastatin exposure is not influenced by mild to moderate renal impairment (CLcr ≥30 mL/min/1.73 m²). Exposure to rosuvastatin is increased to a clinically significant extent in patients with severe renal impairment (CLcr <30 mL/min/1.73 m²) who are not receiving hemodialysis [see Clinical Pharmacology (12.3)].

Renal impairment is a risk factor for myopathy and rhabdomyolysis. Monitor all patients with renal impairment for development of myopathy. In patients with severe renal impairment not on hemodialysis, the recommended starting dosage is 5 mg daily and should not exceed 10 mg daily [see Dosage and Administration (2.5) and Warnings and Precautions (5.1)].

Patients with Renal Impairment Mild to moderate renal impairment (CLcr ≥30 mL/min/1.73 m2) had no influence on plasma concentrations of rosuvastatin. However, plasma concentrations of rosuvastatin increased to a clinically significant extent (about 3‑fold) in patients with severe renal impairment (CLcr <30 mL/min/1.73 m2) not receiving hemodialysis compared with healthy subjects (CLcr >80 mL/min/1.73 m2). Steady-state plasma concentrations of rosuvastatin in patients on chronic hemodialysis were approximately 50% greater compared with healthy volunteer subjects with normal renal function.

Kidney-specific guidance from renalcarematters.com: in preparation.

Dosing: Hepatic impairment

8.7 Hepatic Impairment CRESTOR is contraindicated in patients with acute liver failure or decompensated cirrhosis. Chronic alcohol liver disease is known to increase rosuvastatin exposure. Patients who consume substantial quantities of alcohol and/or have a history of liver disease may be at increased risk for hepatic injury [see Contraindications (4), Warnings and Precautions (5.3) and Clinical Pharmacology (12.3)].

US FDA label

Dosing: Pediatric

Pediatric use (US label) US FDA label

8.4 Pediatric Use The safety and effectiveness of CRESTOR as an adjunct to diet to reduce LDL-C have been established in pediatric patients 8 years of age and older with HeFH. Use of CRESTOR for this indication is based on one 12-week controlled trial with a 40-week open-label extension period in 176 pediatric patients 10 years of age and older with HeFH and one 2‑year open-label, uncontrolled trial in 175 pediatric patients 8 years of age and older with HeFH [see Clinical Studies (14)].

In the 1-year trial with a 12-week controlled phase, there was no detectable effect of CRESTOR on growth, weight, BMI (body mass index), or sexual maturation in patients aged 10 to 17 years. The safety and effectiveness of CRESTOR as an adjunct to other LDL-C-lowering therapies to reduce LDL-C have been established in pediatric patients 7 years of age and older with HoFH.

Use of CRESTOR for this indication is based on a randomized, placebo-controlled, cross-over study in 14 pediatric patients 7 years of age and older with HoFH [see Clinical Studies (14)]. The safety and effectiveness of CRESTOR have not been established in pediatric patients younger than 8 years of age with HeFH, younger than 7 years of age with HoFH, or in pediatric patients with other types of hypercholesterolemia (other than HeFH or HoFH).

Dosing: Older adult

Geriatric use (US label) US FDA label

8.5 Geriatric Use Of the 10,275 patients in clinical studies with CRESTOR, 3,159 (31%) were 65 years and older, and 698 (6.8%) were 75 years and older. No overall differences in safety or effectiveness were observed between these subjects and younger subjects. Advanced age (≥65 years) is a risk factor for CRESTOR-associated myopathy and rhabdomyolysis.

Dose selection for an elderly patient should be cautious, recognizing the greater frequency of decreased hepatic, renal, or cardiac function, and of concomitant disease or other drug therapy and the higher risk of myopathy. Monitor geriatric patients receiving CRESTOR for the increased risk of myopathy [see Warnings and Precautions (5.1)].

Administration

2.1 General Dosage and Administration Information • Administer CRESTOR orally as a single dose at any time of day, with or without food. Swallow the tablets whole. • Assess LDL-C when clinically appropriate, as early as 4 weeks after initiating CRESTOR, and adjust the dosage if necessary. • If a dose is missed, advise patients not to take an extra dose. Resume treatment with the next dose. • When taking CRESTOR with an aluminum and magnesium hydroxide combination antacid, administer CRESTOR at least 2 hours before the antacid [see Drug Interactions (7.2) ].

US FDA label

Dosage forms

Philippines

  • Film-coated tablet: 5 mg, 10 mg, 20 mg, 40 mg
  • Tablet: 5 mg, 10 mg, 20 mg, 40 mg

Registered products in the Philippines

386 products registered with the Food and Drug Administration (FDA) Philippines list Rosuvastatin as the generic name (including products registered under a variant spelling). Registration status changes; confirm a product's current status on the FDA portal before relying on it.

Also registered under: Rosuvastatin (as calcium (1 product). Products registered under these spellings are included in the table and marked.

Verify on PH FDA portal

All registered products386
Philippine FDA-registered products for Rosuvastatin
Package insert
AmvastRosuvastatin (as calcium)
10 mg Film-Coated TabletAlu/Alu Blister Pack x 10’s (Box of 30's and 100's)
RxVAT-exempt
Fredun Pharmaceuticals LimitedIndia
Maraki Pharma Co.Importer: Amb Hk Enterprises Inc.
DRP-12201-06
Jun 29, 2027
ArteonRosuvastatin (as calcium)
20 mg Film-Coated TabletAlu/Alu Blister Strip x 10's
RxVAT-exempt
Interphil Laboratories, Inc.Philippines
—
DRP-13856
Jul 4, 2030
ArterixRosuvastatin (as calcium)
10 mg Film-Coated TabletAlu/Alu Blister Pack x 10's (Box of 100's)
RxVAT-exempt
Magbro Healthcare Pvt. Ltd.India
Radbuster Inc.Importer: Pharmakon Biotec Inc.
DRP-14226-04
Oct 28, 2027
ArterixRosuvastatin (as calcium)
20mg Film-Coated TabletAlu/Alu Blister Pack x 10's (Box of 30's)
RxVAT-exempt
Magbro Healthcare Pvt. Ltd.India
Radbuster Inc.Importer: N/APharmakon Biotec Inc.
DRP-10077-05
Oct 6, 2030
Arvast 10Rosuvastatin (as calcium)
10 mg Film Coated TabletAlu-Alu Blister Pack x 15's
RxVAT-exempt
Intas Pharmaceuticals Ltd.India
Importer: Accord Healthcare Limited - Philippine Branch Office
DRP-8011
Oct 31, 2028
Arvast 20Rosuvastatin (as calcium)
20 mg Film Coated TabletAlu-Alu blister pack x 15's
RxVAT-exempt
INTAS PHARMACEUTICALS LIMITEDIndia
Importer: Accord Healthcare Limited-Philippine Branch Office
DRP-8012
Oct 31, 2028
AtheroRosuvastatin (As Calcium)
10mg Film-Coated TabletAlu/Alu Blister pack x 10's (Box of 30's)
RxVAT-exempt
Bafna Pharmaceuticals LimitedIndia
Kaufmann Pharma Inc.Importer: Medethix, Inc.
DRP-7657
Mar 8, 2031
AtheroRosuvastatin (as calcium)
20 mg Film-Coated TabletAlu/Alu Blister pack of 10's (Box of 30's)
RxVAT-exempt
Bafna Pharmaceuticals LimitedIndia
Kaufmann Pharma Inc.Importer: MedEthix, Inc.
DRP-7993
Sep 27, 2028
AuroraRosuvastatin (as calcium)
10 mg Film-Coated TabletAlu/Alu blister pack x 10 tablets (Box of 100's)
RxVAT-exempt
Ferozsons Laboratories LimitedPakistan
Importer: First Global Trading Corporation
DR-XY46067
Oct 4, 2027
AuroraRosuvastatin (as calcium)
10 mg Film-Coated TabletAlu/Alu blister pack x 10 tablets (Box of 100's)
RxVAT-exempt
Ferozsons Laboratories LimitedPakistan
Importer: First Global Trading Corporation
DRP-11775
Oct 4, 2027
AuroraRosuvastatin (as calcium)
20 mg Film-Coated TabletAlu/Alu blister pack x 10 tablets (Box of 100's)
RxVAT-exempt
Ferozsons Laboratories LimitedPakistan
Importer: First Global Trading Corporation
DR-XY46068
Oct 4, 2027
AuroraRosuvastatin (as calcium)
20 mg Film-Coated TabletAlu/Alu blister pack x 10 tablets (Box of 100's)
RxVAT-exempt
Ferozsons Laboratories LimitedPakistan
Importer: First Global Trading Corporation
DRP-11776
Oct 4, 2027
AuroraRosuvastatin (as calcium)
40 mg Film-Coated TabletAlu/Alu Blister Pack x 10's (Box of 100's)
RxVAT-exempt
Ferozsons Laboratories LimitedPakistan
FIRST GLOBAL TRADING CORPORATION
DRP-11774
Oct 4, 2029
AztinRosuvastatin (as calcium)
20 mg TabletAlu/Alu Blister Pack x 10’s (Box of 100's)
RxVAT-exempt
Magbro Healthcare Pvt. Ltd.India
Janamed CorporationImporter: Teramedix Pharma Trading Inc.
DRP-9986-04
Jul 8, 2031
Better Rozz 10Rosuvastatin (as calcium)
10 mg Film-Coated TabletAlu/Alu Blister Pack x 10's (Box of 30's and 100's)
RxVAT-exempt
Magbro Healthcare Pvt. Ltd.India
Better Option Pharmaceuticals, Inc.Importer: Teramedix Pharma Trading Inc.
DRP-13727-04
Apr 4, 2028
Better Rozz 20Rosuvastatin (as calciumVariant spelling
20 mg TabletAlu/Alu Blister Pack x 10's (Box of 30's and 100's)
Rx
Magbro Healthcare Pvt. LtdIndia
Better Option Pharmaceuticals, Inc.Importer: Teramedix Pharma Trading Inc.
DRP-9986-05
Jul 8, 2031
BEZTINRosuvastatin (as Calcium)
20 mg Film-Coated TabletAlu/Alu Blister Pack x 10's (Box of 30's)
RxVAT-exempt
GRACURE PHARMACEUTICAL LTD.India
BELLUS LIFE SOLUTIONS, INC.Importer: AGLOBAL CARE, INC.
DRP-8482-01
Jan 15, 2029
Cardiostin-10Rosuvastatin (as calcium)
10 mg Film Coated TabletAlu/Alu Blister Pack x 10’s (Box of 3 blister pack x 10’s); Alu/Alu Blister Pack x 10’s (Box of 10 blister pack x 10’s)
RxVAT-exempt
Sapphire Lifesciences Pvt. Ltd.India
777 Red Pharma Inc.Importer: Nelpa Lifesciences, Inc.
DRP-11330-02
Mar 3, 2027
Caroza 40Rosuvastatin (as calcium)
40mg Film Coated TabletAlu/Alu Blister Pack x 10's (Box of 100's)
RxVAT-exempt
Hetero Labs Limited (Unit V)India
Camber Pharmaceuticals, Inc.
DRP-13277
Jan 19, 2028
ChaletinRosuvastatin (as calcium)
10 mg Film-Coated TabletPolyamide/Alu/PVC/Alu-blister Pack (Box of 28's)
RxVAT-exempt
Changzhou Pharmaceutical FactoryChina
Shanghai Pharma (Philippines) Inc.Trader: N/A
DR-XY48616
Feb 10, 2028
ChaletinRosuvastatin (as calcium)
20 mg Film-Coated TabletPolyamide/Alu/PVC/Alu-blister Pack (Box of 28's)
RxVAT-exempt
Changzhou Pharmaceutical FactoryChina
Shanghai Pharma (Philippines) Inc.
DR-XY48617
Feb 10, 2028
ChaletinRosuvastatin (as calcium)
40 mg Film-Coated TabletPolyamide/Alu/PVC/Alu Blister Pack x 7's (Box of 28's)
RxVAT-exempt
Changzhou Pharmaceutical FactoryChina
Luoxin Pharmaceuticals (PH) Corp.
DR-XY48618
Feb 10, 2028
ChaletinRosuvastatin (as calcium)
5 mg Film-Coated TabletPolyamide/Alu/PVC/Alu-blister Pack (Box of 28's)
RxVAT-exempt
Changzhou Pharmaceutical FactoryChina
Shanghai Pharma (Philippines) Inc.Trader: N/A
DR-XY48615
Feb 10, 2028
CholefastRosuvastatin (as calcium)
10 mg Film-Coated TabletAlu/Alu Blister Pack x 10's (Box of 100's)
RxVAT-exempt
Innova Captab LimitedIndia
AGB Pharmaceutical Trading and Consultancy CorporationImporter: Ambica International Corporation
DRP-6405-05
Jun 9, 2031
CholestrovasRosuvastatin (as calcium)
40 mg Film-Coated TabletAlu/Alu Blister Pack x 10's (Box of 30's and 100's)
RxVAT-exempt
S Kant Healthcare Ltd.India
GA2 Pharmaceutical IncImporter: Medinova Pharmaceutical Inc.
DRP-17690-01
Feb 18, 2031
CholsuvinRosuvastatin (as Calcium)
20 mg Film-Coated TabletAlu-Alu Blister Pack x 10's (Box of 30's)
RxVAT-exempt
PSA Chemicals & Pharmaceuticals Pvt. Ltd.India
Ambicare Pharmaceuticals Inc.Importer: Ambica International CorporationTrader: Rainbow Life Sciences Pvt. Ltd.
DRP-15093-02
Apr 23, 2029
ColestrovasRosuvastatin (as calcium)
10 mg Film-Coated TabletAlu / Alu Blister Pack x 10's (Box of 30's and 100's)
RxVAT-exempt
S Kant Healthcare Ltd.India
GA2 Pharmaceutical IncImporter: Medinova Pharmaceutical Inc.
DRP-17698-01
Feb 19, 2031
Controld 20Rosuvastatin (as calcium)
20 mg Film-Coated TabletAlu/Alu blister pack x 10's (Box of 30's)
RxVAT-exempt
Stallion Laboratories Pvt. Ltd.India
Preventia Healthcare Inc.Importer: Ambica International Corporation
DRP-8300-02
Aug 7, 2029
CosuvastRosuvastatin (as calcium)
10 mg Film-Coated TabletAlu/Alu Blister Pack x 10’s (Box of 100’s)
RxVAT-exempt
Hizon Laboratories, Inc.Philippines
Medport Distributors Inc.
DRP-8448
May 25, 2031
CrestarRosuvastatin (as calcium)
20 mg Film-Coated TabletAlu/Alu blister pack of 10's (Box of 30's and 100's)
RxVAT-exempt
Stallion Laboratories Pvt. Ltd.India
Diafarm Inc.Importer: Ambica International Corporation
DRP-8300-03
Aug 7, 2029
CrestatRosuvastatin (as calcium)
10 mg Film-Coated TabletAlu/Alu blister pack x 10’s (Box of 100's)
RxVAT-exempt
Baroque Pharmaceuticals Pvt. Ltd.India
CCL Pharmaceuticals (Philippines), Inc.Importer: AMB HK Enterprises Inc.
DRP-16322-02
Jun 3, 2030
CrestatRosuvastatin (as calcium)
20 mg Film-Coated TabletAlu/Alu blister pack x 10’s (Box of 100's)
RxVAT-exempt
Baroque Pharmaceuticals Pvt. Ltd.India
CCL Pharmaceuticals (Philippines), Inc.Importer: AMB HK Enterprises Inc.
DRP-16323-01
Jun 3, 2030
CrestatRosuvastatin (as calcium)
5 mg Film-Coated TabletAlu/Alu blister pack x 10’s (Box of 100's)
RxVAT-exempt
Baroque Pharmaceuticals Pvt. Ltd.India
CCL Pharmaceuticals (Philippines), Inc.Importer: AMB HK Enterprises Inc.
DRP-16321-01
Jun 3, 2030
CrestinRosuvastatin (as Calcium)
20 mg Film-Coated TabletAlu-Alu Blister Pack x 10's (Box of 100's)
RxVAT-exempt
PSA Chemicals & Pharmaceuticals Pvt. Ltd.India
Diafarm Inc.Importer: Ambica International CorporationTrader: Rainbow Life Sciences Pvt. Ltd.
DRP-15093-04
Apr 23, 2029
Crestodix-10Rosuvastatin (as calcium)
10 mg Film-Coated TabletAlu/Alu Blister Pack x 10's (Box of 30's)
RxVAT-exempt
Zim Laboratories LimitedIndia
Teramedix Pharma Trading Inc.
DR-XY47573
Nov 29, 2031
Crestodix-20Rosuvastatin (as calcium)
20 mg Film-Coated TabletAlu/Alu Blister Pack x 10's (Box of 30's)
RxVAT-exempt
Zim Laboratories LimitedIndia
Teramedix Pharma Trading Inc.
DR-XY47572
Nov 29, 2031
CrestorRosuvastatin (as calcium)
10 mg Film-Coated TabletAlu/Alu Blister Pack x 15's (Box of 30's)
RxVAT-exempt
IPR Pharmaceuticals IncorporatedPuerto Rico
Importer: AstraZeneca Pharmaceuticals (Phils.), Inc.Trader: AstraZeneca UK Ltd.
DRP-8017
Aug 5, 2031
CrestorRosuvastatin (as calcium)
20 mg Film-Coated TabletAlu/Alu Blister Pack x 15's (Box of 30's)
RxVAT-exempt
IPR Pharmaceuticals IncorporatedPuerto Rico
Importer: AstraZeneca Pharmaceuticals (Phils.), Inc.Trader: AstraZeneca UK Ltd.
DRP-8016
Aug 5, 2031
CrestorRosuvastatin (as calcium)
40 mg Film-Coated TabletAlu/Alu Blister Pack x 10's (Box of 30's)
RxVAT-exempt
IPR Pharmaceuticals IncorporatedPuerto Rico
Importer: AstraZeneca Pharmaceuticals (Phils.), Inc.Trader: AstraZeneca UK Ltd.
DR-XY28497
Mar 18, 2031
CrestorRosuvastatin (as calcium)
5 mg Film-Coated TabletAlu/Alu Blister Pack x 15's (Box of 30's)
RxVAT-exempt
IPR Pharmaceuticals IncorporatedPuerto Rico
Importer: AstraZeneca Pharmaceuticals (Phils.), Inc.Trader: AstraZeneca UK Ltd.
DR-XY31354
Aug 5, 2031
Cresvid 20Rosuvastatin (as calcium)
20 mg Film-Coated TabletAlu/Alu Blister Pack x 10's (Box of 10's. 30's and 100's)
RxVAT-exempt
Hovid BerhadMalaysia
Hovid Berhad
DRP-15718
Sep 5, 2029
DelteriaRosuvastatin (as calcium)
10 mg Film-Coated TabletAlu / Alu Blister Pack x 10's (Box of 100's)
RxVAT-exempt
Magbro Healthcare Pvt. Ltd.India
NAB Trading Corp.Importer: Pharmakon Biotec Inc.
DRP-14226-05
Oct 28, 2027
DelteriaRosuvastatin (as calcium)
20 mg TabletAlu/Alu Blister Pack x 10's (Box of 30's)
RxVAT-exempt
Magbro Healthcare Pvt. Ltd.India
NAB Trading Corp.Importer: Pharmakon Biotec Inc.
DRP-10077-09
Oct 6, 2030
DismigrasRosuvastatin (as calcium)
10 mg Film-Coated TabletAlu/Alu Blister Pack of 10's (Box of 100's)
RxVAT-exempt
MSN Laboratories Private Limited (Formulations Division)India
MSN Labs Philippines Inc.Importer: Healol Pharma Corporation
DRP-10373-01
Jul 29, 2028
DismigrasRosuvastatin (as calcium)
20 mg Film-Coated TabletAlu/Alu Blister Pack of 10's (Box of 100's)
RxVAT-exempt
MSN Laboratories Private Limited (Formulations Division)India
MSN Labs Philippines Inc.Importer: Healol Pharma Corporation
DRP-10117-01
Jul 28, 2028
FadztatRosuvastatin (as calcium)
20 mg Film-Coated TabletAlu/Alu Blister Pack of 10's (Box of 30's)
RxVAT-exempt
Stallion Laboratories Pvt. Ltd.India
Fadz Pharma Inc.Importer: Ambica International Corporation
DRP-8300-06
Aug 7, 2029
FusovastRosuvastatin (as calcium)
20 mg Film-Coated TabletAlu/Alu Blister Pack x 10’s (Box of 30’s)
RxVAT-exempt
Sava Healthcare Ltd.India
Ambica International Corporation
DRP-10597
Oct 21, 2031
Glenraz 10Rosuvastatin (as calcium)
10 mg Film-Coated TabletAlu/Alu Blister Pack x 10's (Box of 30's)
RxVAT-exempt
Glenmark Pharmaceuticals LimitedIndia
Glenmark Philippines, Inc.
DRP-14878
Jan 31, 2029
Glenraz 40Rosuvastatin (as calcium)
40 mg Film-Coated TabletAlu/Alu Blister Pack x 10's (Box of 30's)
RxVAT-exempt
Glenmark Pharmaceuticals LimitedIndia
Glenmark Philippines, Inc.
DRP-14877
Jan 31, 2029
Glenraz 5Rosuvastatin (as calcium)
5 mg Film-Coated TabletAlu/Alu Blister Pack x 10's (Box of 30's)
RxVAT-exempt
Glenmark Pharmaceuticals LimitedIndia
Glenmark Philippines, Inc.
DRP-14879
Jan 31, 2029
Gorovast 20Rosuvastatin (as Calcium)
20 mg Film-Coated TabletAlu/Alu Blister Pack x 10’s (Box of 30’s and 100’s)
RxVAT-exempt
Fredun Pharmaceuticals LimitedIndia
Applied Pharmaceutical Distribution Inc.Importer: AMB HK Enterprises Inc.
DRP-12200-03
Jun 29, 2027
Gorovast 40Rosuvastatin (as calcium)
40 mg Film-Coated TabletAlu/Alu Blister Pack x 10’s (Box of 100’s)
RxVAT-exempt
Fredun Pharmaceuticals LimitedIndia
Applied Pharmaceutical Distribution IncImporter: AMB HK Enterprises, India
DRP-12140-01
Jun 20, 2027
Gorovast-10Rosuvastatin (as calcium)
10 mg Film-Coated TabletAlu/Alu Blister Pack x 10's (Box of 100's)
RxVAT-exempt
Fredun Pharmaceuticals LimitedIndia
Applied Pharmaceutical Distribution Inc.Importer: AMB HK Enterprises Inc.
DRP-12201-03
Jun 29, 2027
Gorovast-20Rosuvastatin (as Calcium)
20 mg Film-Coated TabletAlu-Alu Blister Pack x 10’s (Box of 100’s)
RxVAT-exempt
PSA Chemicals & Pharmaceuticals Pvt. Ltd.India
Applied Pharmaceutical Distribution IncImporter: Ambica International CorporationTrader: Rainbow Life Sciences Pvt. Ltd.
DRP-15093-08
Apr 23, 2029
Goroztin-10Rosuvastatin (as calcium)
10 mg Film-Coated TabletAlu/Alu Blister Pack x 10's (Box of 30's)
RxVAT-exempt
Umedica Laboratories Pvt. Ltd.India
Applied Pharmaceutical Distribution Inc.Importer: Suhitas Pharmaceuticals Inc.
DRP-9314-06
Sep 4, 2031
Gostatin 20Rosuvastatin (as Calcium)
20 mg Film-Coated TabletAlu/Alu Blister Pack x 10's (Box of 30's)
RxVAT-exempt
Stallion Laboratories Pvt. Ltd.India
Applied Pharmaceutical Distribution IncImporter: Ambica International Corporation
DRP-8300-01
Aug 7, 2029
Jiaavast-10Rosuvastatin (as calcium)
10 mg Film-Coated TabletAlu/Alu Blister Pack x 10's (Box of 30's)
RxVAT-exempt
Umedica Laboratories Pvt. Ltd.India
Jiaa PharmaImporter: Suhitas Pharmaceuticals Inc.
DRP-9314-05
Sep 22, 2031
Jiaavast-20Rosuvastatin (as calcium)
20 mg Film-Coated TabletAlu/Alu Blister Pack x 10's (Box of 30's)
RxVAT-exempt
Umedica Laboratories Pvt. Ltd.India
Jiaa PharmaImporter: Suhitas Pharmaceuticals Inc.
DRP-9315-06
Aug 17, 2031
JivastatinRosuvastatin (as calcium)
10 mg Film-Coated TabletAlu/Alu Blister Pack x 10's (Box of 100's)
RxVAT-exempt
Fredun Pharmaceuticals LimitedIndia
Jiaa PharmaImporter: AMB HK Enterprises Inc.
DRP-12201-05
Jun 29, 2027
Kingstat 10Rosuvastatin (as calcium)
10 mg Film-Coated TabletCold Form Foil Blister x 10's Box of 3 blister pack x 10's
RxVAT-exempt
Sun Pharmaceutical Industries LimitedIndia
Sun Pharma Philippines, Inc.
DRP-10820
Dec 3, 2031
Kingstat 20Rosuvastatin (as calcium)
20 mg Film-Coated TabletCold Form Foil Blister Pack x 10's Box of 3 blister pack x 10's
RxVAT-exempt
Sun Pharmaceutical Industries LimitedIndia
Importer: Sun Pharma Philippines, Inc.
DRP-10823
Dec 3, 2031
Kingstat 40Rosuvastatin (as calcium)
40 mg Film-Coated TabletCold Form Foil Blister Pack x 10's (Box of 3 blister packs x 10's)
RxVAT-exempt
Sun Pharmaceutical Industries LimitedIndia
Sun Pharma Philippines, Inc.
DRP-10822
Dec 3, 2031
Kingstat 5Rosuvastatin (as calcium)
5 mg Film-Coated TabletCold Form Foil Blister x 10's (Box of 3 blister packs x 10's)
RxVAT-exempt
Sun Pharmaceutical Industries LimitedIndia
Importer: Sun Pharma Philippines, Inc.
DRP-10821
Dec 3, 2031
LdnilRosuvastatin (as calcium)
10 mg Film-Coated TabletAlu/Alu Blister Pack of 10's Box of 100's
RxVAT-exempt
MSN LABORATORIES PRIVATE LIMITED (FORMULATIONS DIVISION)India
Healol Pharma Corporation
DRP-10373
Jul 29, 2028
LdnilRosuvastatin (as calcium)
20 mg Film-Coated TabletAlu/Alu Blister Pack of 10's (Box of 100's)
RxVAT-exempt
MSN Laboratories Private Limited (Formulations Division)India
Healol Pharma Corporation
DRP-10117
Jul 28, 2028
LipicoreRosuvastatin
10 mg Film Coated TabletAlu-PVC/PE Blister pack x 10's (Box of 100's)
RxVAT-exempt
Titan Laboratories Pvt. Ltd.India
Greencore Pharma Inc.Importer: Triple Tact Import & Export Corp.
DRP-18253-01
Jun 3, 2031
LipidarRosuvastatin (as calcium)
10 mg Film-Coated TabletAlu/Alu Blister Pack x 10's (Box of 100's)
RxVAT-exempt
Magbro Healthcare Pvt. Ltd.India
Vitalife Pharma & Medical Supply Inc.Importer: Pharmakon Biotec Inc.
DRP-14226-06
Oct 28, 2027
LipidarRosuvastatin (as calcium)
40 mg Film-Coated TabletAlu/Alu Blister Pack x 10's (Box of 100's)
RxVAT-exempt
Curis Lifesciences LimitedIndia
Vitalife Pharma & Medical Supply Inc.Importer: Philgen Pharmaceuticals Inc.
DRP-14701-01
Nov 30, 2028
LipidblocRosuvastatin (as calcium)
10 mg Film-Coated TabletAlu/Alu Blister Pack x 10's (Box of 30's)
RxVAT-exempt
Healer's Lab (Unit II)India
Pharmakon Biotec, Inc.
DRP-15044
Mar 26, 2029
LipidblocRosuvastatin (as calcium)
20 mg Film-Coated TabletAlu/Alu Blister Pack x 10's (box for 30's)
RxVAT-exempt
Healer's Lab (Unit II)India
Pharmakon Biotec, Inc.
DRP-14891
Feb 1, 2029
LipidblocRosuvastatin (as calcium)
40 mg Film-Coated TabletAlu/Alu Blister Pack x 10's (box for 30's)
RxVAT-exempt
Healer's Lab (Unit II)India
Pharmakon Biotec Inc.
DRP-16839
Jul 16, 2030
Lipiguard-10Rosuvastatin (as calcium)
10 mg Film-Coated TabletAlu/Alu Blister Pack x 10's (Box of 30's)
RxVAT-exempt
Umedica Laboratories Pvt. Ltd.India
Orange Biotec Inc.Importer: Suhitas Pharmaceuticals Inc.
DRP-9314-02
Sep 23, 2031
Lipiguard-20Rosuvastatin (as calcium)
20 mg Film-Coated TabletAlu/Alu Blister Pack x 10's (Box of 30's)
RxVAT-exempt
Umedica Laboratories Pvt. Ltd.India
Orange Biotec Inc.Importer: Suhitas Pharmaceuticals Inc.
DRP-9315-02
Aug 17, 2031
LipiruvinRosuvastatin (as Calcium)
10 mg Film-Coated TabletAlu-Alu Blister Pack x 10's (Box of 30's)
RxVAT-exempt
PSA Chemicals & Pharmaceuticals Pvt. Ltd.India
HealthPrescription, Inc.Importer: Ambica International CorporationTrader: Rainbow Life Sciences Pvt. Ltd.
DRP-15849-02
Sep 23, 2029
LipiruvinRosuvastatin (as Calcium)
20 mg Film-Coated TabletAlu-Alu Blister Pack x 10's (Box of 30's)
RxVAT-exempt
PSA Chemicals & Pharmaceuticals Pvt. Ltd.India
AGB Pharmaceutical Trading and Consultancy CorporationImporter: Ambica International CorporationTrader: Rainbow Life Sciences Pvt. Ltd.
DRP-15093-01
Apr 23, 2029
Lipvast 40Rosuvastatin (as calcium)
40 mg Film Coated TabletAlu/Alu Blister Pack x 10's (Box of 30's)
RxVAT-exempt
East African (India) OverseasIndia
Airlife International Trading Corporation
DRP-17003
Sep 4, 2030
LowasRosuvastatin (as Calcium)
5 mg Film-Coated TabletAlu/Alu Blister Pack x 7’s (Box of 28’s)
RxVAT-exempt
XL Laboratories Pvt. Ltd.India
Ambica International Corporation
DR-XY45239
Apr 5, 2038
LowasRosuvastatin (as Calcium)
5 mg Film-Coated TabletAlu/Alu Blister Pack x 7’s (Box of 28’s)
RxVAT-exempt
XL Laboratories Pvt. Ltd.India
Ambica International Corporation
DRP-16661
Apr 5, 2038
Lowas 10Rosuvastatin (as calcium)
10 mg Film-Coated TabletAlu/Alu Blister Pack x 7’s (Box of 28’s and 98’s); Alu/Alu Blister Pack x 10’s (Box of 100’s)
RxVAT-exempt
XL Laboratories Pvt. Ltd.India
Ambica International Corporation
DRP-13024
Mar 23, 2030
Lustatin-40Rosuvastatin (as Calcium)
40 mg TabletAlu/Alu Blister Strip x 10's (Box of 30's)
RxVAT-exempt
SIMPEX PHARMA PVT. LTD.India
Bell-Kenz Pharma Inc.Importer: SRS Life Sciences Inc.
DR-XY43256
Feb 28, 2029
Lustatin-5Rosuvastatin (As Calcium)
5 mg TabletAlu/Alu Blister Strip x 10's (Box of 30's)
RxVAT-exempt
Simplex Pharma Pvt. Ltd.India
SRS Life Sciences Inc.
DR-XY43219
May 19, 2027
MayrosuRosuvastatin (as calcium)
10 mg Film-Coated TabletAlu/Alu Blister Pack x 10's (Box of 30's and 100's)
RxVAT-exempt
Magbro Healthcare Pvt. Ltd.India
Alternative Platform Exchange, Inc.Importer: Teramedix Pharma Trading Inc.
DRP-13727-02
Apr 4, 2028
NoneRosuvastatin Calcium
10 mg Film-Coated TabletAlu/Alu Blister Pack x 10's (Box of 30's)
RxVAT-exempt
Lloyd Laboratories, Inc.Philippines
TGP Pharma Inc.Trader: Euro-Health Care Exponents, Inc.
DR-XY44197
Feb 12, 2030
NoneRosuvastatin (as calcium)
10 mg Film-Coated TabletAlu/Alu Blister Pack x 10's (Box of 30's); Alu/Alu Blister Pack x 10's (Box of 100's); Alu/Alu Blister Pack x 10's (Box of 10's as Physician's Sample)
RxVAT-exempt
Zydus Lifesciences LimitedIndia
Zydus Healthcare Philippines Inc.
DRP-10055
Aug 9, 2031
NoneRosuvastatin Calcium
10 mg Film-Coated TabletAlu/Alu Blister Pack x 10's (Box of 30's)
RxVAT-exempt
Lloyd Laboratories, Inc.Philippines
Trader: Westfield Pharmaceuticals, Inc.
DRP-10085
Feb 23, 2030
NoneRosuvastatin Calcium
10 mg Film-Coated TabletAlu/Alu Blister Pack x 10's (Box of 30's)
RxVAT-exempt
Lloyd Laboratories, Inc.Philippines
Watsons Personal Care Stores (Philippines), Inc.Trader: Westfield Pharmaceuticals, Inc.
DRP-10085-01
Feb 23, 2030
NoneRosuvastatin(as calcium)
10 mg Film-Coated TabletAlu/Alu Blister Pack x 10's (Box of 100's)
RxVAT-exempt
Fredun Pharmaceuticals LimitedIndia
Dyna Drug CorporationImporter: AMB HK Enterprises Inc.
DRP-12201-04
Jun 29, 2027
NoneRosuvastatin (as Calcium)
10 mg Film-Coated TabletAlu/Alu Blister Pack x 10's (Box of 30's and 100's) and (Box of 1's) as Physician's Sample
RxVAT-exempt
Pharmevo (Pvt) LimitedPakistan
Reta DrugImporter: Accesspoint International Trading Inc.
DRP-12702-06
May 11, 2030
NoneRosuvastatin (as calcium)
10 mg Film-Coated TabletAlu/Alu Blister pack x 10's (Box of 30's and 100's)
RxVAT-exempt
Magbro Healthcare Pvt. Ltd.India
Reta DrugImporter: Teramedix Pharma Trading Inc.
DRP-13727-06
Apr 4, 2028
NoneRosuvastatin (as calcium)
10 mg Film-Coated TabletAlu / Alu Blister Pack x 10’s (Box of 100’s)
RxVAT-exempt
Baroque Pharmaceuticals Private LimitedIndia
Qualifirst Health Inc.Importer: AMB HK Enterprises Inc.
DRP-16322-01
Jun 3, 2030
NoneRosuvastatin (as Calcium)
10 mg Film-Coated TabletAlu/Alu Blister Pack x 10's (Box of 30's)
RxVAT-exempt
Zim Laboratories Ltd.India
Actimed, Inc.Importer: Ambica International CorporationTrader: Rainbow Life Sciences Pvt. Ltd.
DRP-6002-03
Feb 10, 2030
NoneRosuvastatin (as Calcium)
10 mg Film-Coated TabletAlu/Alu Blister Pack x 10's (Box of 30's)
RxVAT-exempt
Zim Laboratories Ltd.India
AGB Pharmaceutical Trading and Consultancy CorporationImporter: Ambica International CorporationTrader: Rainbow Life Sciences Pvt. Ltd.
DRP-6002-06
Feb 10, 2030
NoneRosuvastatin (as Calcium)
10 mg Film-Coated TabletAlu/Alu Blister Pack x 10's (Box of 30's)
RxVAT-exempt
Zim Laboratories Ltd.India
Aristo Pharma Philippines, Inc.Importer: Ambica International CorporationTrader: Rainbow Life Sciences Pvt. Ltd.
DRP-6002-08
Feb 10, 2030
NoneRosuvastatin (as calcium)
10 mg Film-Coated TabletAlu/Alu Blister Pack x 10's (Box of 100's)
RxVAT-exempt
Innova Captab LimitedIndia
Reta DrugImporter: Ambica International Corporation
DRP-6405-06
Oct 15, 2030
NoneRosuvastatin (as Calcium)
10 mg Film-Coated TabletAlu/Alu Blister Pack x 10’s (Box of 10’s)
RxVAT-exempt
Maple Pharmaceuticals (Pvt.) Ltd.Pakistan
Diafarm Inc.Importer: Ambica International Corporation
DRP-6650-01
Feb 1, 2032
NoneRosuvastatin (as calcium)
10 mg Film-Coated TabletAlu/Alu Blister Pack x 10's (Box of 30's and 100's)
RxVAT-exempt
Hizon Laboratories, Inc.Philippines
Actimed, Inc.
DRP-6743-03
Mar 30, 2030
NoneRosuvastatin (as calcium)
10 mg Film-Coated TabletAlu/Alu Blister Pack x 10's Box of 30's and 100's
RxVAT-exempt
Hizon Laboratories, Inc.Philippines
TGP Pharma Inc.
DRP-6743-04
Mar 30, 2030
NoneRosuvastatin (as calcium)
10 mg Film-Coated TabletAlu/Alu Blister Pack x 10’s (Box of 100's)
RxVAT-exempt
Hizon Laboratories, Inc.Philippines
Rose Pharmacy, Incorporated
DRP-6743-05
Mar 30, 2030
NoneRosuvastatin (As Calcium)
10 mg Film-Coated TabletAlu/Alu Blister pack x 10's (Box of 30's)
RxVAT-exempt
Bafna Pharmaceuticals LimitedIndia
Patriot Pharmaceuticals CorporationImporter: Medethix, Inc.
DRP-7657-01
Mar 8, 2031
NoneRosuvastatin (as calcium)
10 mg Film-Coated TabletAlu/Alu Blister Pack x 10's (Box of 30's)
RxVAT-exempt
Bafna Pharmaceuticals LimitedIndia
St. JOSEPH DRUGSTOREImporter: Medethix, Inc.
DRP-7657-04
Feb 1, 2032
NoneRosuvastatin (as calcium)
10 mg Film-Coated TabletAlu-Alu Blister x 10 (Box of 30's)
RxVAT-exempt
Theragen Etex Co., Ltd.Republic of Korea
RITEMED PHILS., INC.
DRP-7717
Mar 6, 2028
NoneRosuvastatin (as Calcium)
10mg Film-Coated TabletAlu/Alu Blister pack x 10's (Box of 30's)
RxVAT-exempt
Bafna Pharmaceuticals LimitedIndia
Actimed, Inc.Importer: Medethix, Inc
DRP-7657-03
Feb 4, 2032
NoneRosuvastatin (as calcium)
20 mg Film-Coated TabletAlu/Alu Blister Pack x 10's Box of 30's; Alu/Alu Blister Pack x 10's Box of 100's; Alu/Alu Blister Pack x 10's Box of 10's as Physician's Sample
RxVAT-exempt
Zydus Lifesciences LimitedIndia
Zydus Healthcare Philippines Inc.
DRP-10054
Aug 9, 2031
NoneRosuvastatin (as calcium)
20 mg Film-Coated TabletAlu/Alu Blister Pack x 10's (Box of 100's)
RxVAT-exempt
Fredun Pharmaceuticals LimitedIndia
Dyna Drug CorporationImporter: AMB HK Enterprises, Inc.
DRP-12200-02
Jun 29, 2027
NoneRosuvastatin (as calcium)
20 mg Film-Coated TabletLaminated Aluminum Foil Strip x 10's (Box of 100's)
RxVAT-exempt
Interphil Laboratories, Inc.Philippines
South Star Drug
DRP-13856-01
Jul 4, 2030
NoneRosuvastatin (as calcium)
20 mg Film-Coated TabletLaminated Aluminum Foil Strip x 10's (Box of 100's)
RxVAT-exempt
Interphil Laboratories, Inc.Philippines
Rose Pharmacy, Incorporated
DRP-13856-02
Jul 4, 2030
NoneRosuvastatin (as Calcium)
20 mg Film-Coated TabletLaminated Aluminum Foil Strip x 10's (Box of 100's)
RxVAT-exempt
Interphil Laboratories, Inc.Philippines
Icon Healthcare, Inc.
DRP-13856-04
Jul 4, 2030
NoneRosuvastatin (as Calcium)
20 mg Film-Coated TabletAlu-Alu Blister Pack x 10's (Box of 100's)
RxVAT-exempt
PSA Chemicals & Pharmaceuticals Pvt. Ltd.India
Reta DrugImporter: Ambica International CorporationTrader: Rainbow Life Sciences Pvt. Ltd.
DRP-15093-03
Apr 23, 2029
NoneRosuvastatin (as calcium)
20 mg Film-Coated TabletAlu/Alu blister pack x 10’s (Box of 100’s)
RxVAT-exempt
Baroque Pharmaceuticals Private LimitedIndia
Qualifirst Health Inc.Importer: AMB HK Enterprises Inc.
DRP-16323-02
Jun 3, 2030
NoneRosuvastatin (as calcium)
20 mg Film-Coated TabletAlu/Alu Blister Pack x 10's (Box of 30's)
RxVAT-exempt
Bafna Pharmaceuticals Limited (Unit II)India
Actimed, Inc.Importer: Medethix, Inc.
DRP-7993-01
Sep 27, 2028
NoneRosuvastatin (as calcium)
20 mg Film-Coated TabletAlu/Alu Blister Pack of 10's (Box of 30's)
RxVAT-exempt
Bafna Pharmaceuticals LimitedIndia
St. Joseph DrugstoreImporter: Medethix Inc.
DRP-7993-04
Sep 27, 2028
NoneRosuvastatin (as calcium)
20 mg Film-Coated TabletAlu/Alu Blister pack of 10's (Box of 30's)
RxVAT-exempt
Bafna Pharmaceuticals LimitedIndia
Patriot Pharmaceuticals CorporationImporter: Medethix, Inc.
DRP-7993-05
Sep 27, 2028
NoneRosuvastatin Calcium
20 mg Film-Coated TabletAlu/Alu Blister Pack x 10's (Box of 30's)
RxVAT-exempt
Lloyd Laboratories, Inc.Philippines
TGP Pharma Inc.Trader: Euro-Health Care Exponents, Inc.
DRP-8108
Feb 11, 2030
NoneRosuvastatin (as calcium)
20 mg Film-Coated TabletAlu/Alu Blister Pack x 10's (Box of 30's)
RxVAT-exempt
Stallion Laboratories Pvt. Ltd.India
Aristo Pharma Philippines, Inc.Importer: Ambica International Corporation
DRP-8300-05
Aug 7, 2029
NoneRosuvastatin (as calcium)
20 mg Film-Coated TabletAlu/Alu Blister Pack of 10's (Box of 30's)
RxVAT-exempt
Stallion Laboratories Pvt. Ltd.India
AGB Pharmaceutical Trading and Consultancy CorporationImporter: Ambica International Corporation
DRP-8300-09
Aug 7, 2029
NoneRosuvastatin (as calcium)
20 mg TabletAlu/Alu Blister Pack of 10's (Box of 30's and 100’s)
RxVAT-exempt
Magbro Healthcare Pvt. Ltd.India
Reta DrugImporter: Teramedix Pharma Trading Inc.
DRP-9986-03
Jul 8, 2031
NoneRosuvastatin (as calcium)
20mg Film-Coated TabletAlu/Alu Blister Pack x 10's (Box of 30's)
RxVAT-exempt
Magbro Healthcare Pvt. Ltd.India
Watsons Personal Care Stores (Philippines), Inc.Importer: Pharmakon Biotec Inc.
DRP-10077-04
Oct 6, 2030
NoneRosuvastatin
40 mg Film-coated TabletAlu/Alu Blister Pack x 10's (Box of 100's)
RxVAT-exempt
Medisure Laboratories Pakistan (Pvt.) Ltd.Pakistan
Reta DrugImporter: Accesspoint International Trading Inc.
DRP-17515-01
Jan 16, 2031
One-Rosu 20Rosuvastatin (As Calcium)
20 mg Film-Coated TabletAlu/Alu Blister Pack x 15's (Box of 90's)
RxVAT-exempt
Intas Pharmaceuticals Limited.India
One Dexcel Pharma Inc.
DRP-13960
May 25, 2028
Pausolip-20Rosuvastatin (as calcium)
20 mg Film-Coated TabletAlu/Alu Blister Pack x 10’s Box of 30’s
RxVAT-exempt
Zim Laboratories LimitedIndia
Suhitas Pharmaceuticals Inc.Trader: PSA International (Export Division of PSA Chemicals and Pharmaceuticals Pvt. Ltd.)
DRP-2188
Dec 4, 2029
PrehartRosuvastatin (as calcium)
10 mg Film-Coated TabletAlu/Alu Blister Pack x 10’s (Box of 100’s)
RxVAT-exempt
Hizon Laboratories, Inc.Philippines
Pharma Dynamic, Inc.
DRP-6743-06
Mar 30, 2030
PresuvasRosuvastatin (as Calcium)
10 mg Film-Coated TabletAlu/Alu Blister Pack x 10's (Box of 30's and Box of 1's as Physician's Sample)
RxVAT-exempt
PharmEvo (Pvt.) Ltd.Pakistan
Prebiotech Advanced Pharma Inc.Importer: Accesspoint International Trading Inc.
DRP-12702-05
Mar 6, 2037
RainsuvastRosuvastatin (as calcium)
10 mg Film-Coated TabletAlu/Alu Blister Pack x 10's (Box of 100's)
RxVAT-exempt
Fredun Pharmaceuticals LimitedIndia
United Pharma Plus (Unipharma) Inc.Importer: AMB HK Enterprises, Inc.
DRP-12201-01
Jun 29, 2027
ReestatinRosuvastatin (as Calcium)
10 mg Film-Coated TabletAlu/Alu Blister Pack x 10's (Box of 100's)
RxVAT-exempt
Pharmevo (Pvt) LimitedPakistan
Maed Pharma CorporationImporter: Accesspoint International Trading Inc.
DRP-12702-07
May 11, 2030
RegistatinRosuvastatin (as Calcium)
10 mg Film-Coated TabletAlu/ Alu Blister Pack x 10's (Box of 30's, 50's & 100's)
RxVAT-exempt
Azarias Pharmaceutical Laboratories Inc.Philippines
Regimed Pharmaceutical Distributor
DRP-16595-04
May 13, 2030
RegistatinRosuvastatin (as Calcium)
20 mg Film-Coated TabletAlu/Alu Blister Pack x 10's (Box of 30's, 50's and 100's)
RxVAT-exempt
Azarias Pharmaceutical Laboratories Inc.Philippines
Regimed Pharmaceutical Distributor
DRP-16586-04
May 8, 2030
RegistatinRosuvastatin (as Calcium)
5 mg Film-Coated TabletAlu/Alu Blister Pack x 10's (Box of 30's, 50's & 100's)
RxVAT-exempt
Azarias Pharmaceutical Laboratories Inc.Philippines
Regimed Pharmaceutical Distributor
DRP-16945-01
Sep 2, 2030
RevascRosuvastatin (as calcium)
10 mg Film-Coated TabletAlu/Alu Blister Pack of 10's (Box of 30's)
RxVAT-exempt
Lloyd Laboratories, Inc.Philippines
Trader: Metz Pharmaceuticals, Inc.
DR-XY44893
Nov 24, 2030
RevascRosuvastatin (as calcium)
20 mg Film-Coated TabletAlu/Alu Blister Pack x 10's (Box of 30's)
RxVAT-exempt
Lloyd Laboratories, Inc.Philippines
Trader: Metz Pharmaceuticals, Inc.
DR-XY44808
Sep 2, 2030
RhosaRosuvastatin (as Calcium)
10 mg Film-Coated TabletAlu-Alu Blister Pack x 10's (Box of 30's)
RxVAT-exempt
PSA Chemicals & Pharmaceuticals Pvt. Ltd.India
Ambicare Pharmaceuticals Inc.Importer: Ambica International CorporationTrader: Rainbow Life Sciences Pvt. Ltd.
DRP-15849-01
Sep 23, 2029
RobestarRosuvastatin (as Calcium)
10 mg Film-Coated TabletAlu/Alu Blister Pack x 7’s (Box of 28’s); Alu/Alu Blister Pack x 10’s (Box of 30’s)
RxVAT-exempt
Novartis Pharmaceutical Manufacturing LLCSlovenia
Importer: Sandoz Philippines Corporation
DRP-6491
Jan 12, 2031
RobestarRosuvastatin (as Calcium)
20 mg Film-Coated TabletAlu/Alu Blister Pack x 7’s (Box of 28’s); Alu/Alu Blister Pack x 10’s (Box of 30’s)
RxVAT-exempt
Novartis Pharmaceutical Manufacturing LLCSlovenia
Importer: Sandoz Philippines Corporation
DRP-6489
Jan 12, 2031
Rofast 10Rosuvastatin (As Calcium)
10mg TabletAlu/Alu Blister Pack x 10's (Box of 30's)
RxVAT-exempt
Aurobindo Pharma Limited (Unit VII)India
Macropharma Corporation
DR-XY47624
Dec 22, 2026
Rofast 20Rosuvastatin (As Calcium)
20mg TabletAlu/Alu Blister Pack x 10's (Box of 30's)
RxVAT-exempt
Aurobindo Pharma Limited (Unit VII)India
Macropharma Corporation
DR-XY47263
Dec 22, 2026
Rofast 40Rosuvastatin (As Calcium)
40mg TabletAlu/Alu Blister Pack x 10's (Box of 30's)
RxVAT-exempt
Aurobindo Pharma Limited (Unit VII)India
Macropharma Corporation
DR-XY47622
Dec 22, 2026
Rosadoc-10Rosuvastatin (as calcium)
10 mg Film-Coated tabletAlu/Alu Blister Pack x 10's (Box of 30's)
RxVAT-exempt
Rhydburg Pharmaceuticals Ltd.India
Genedrift Philippines Opc
DRP-7037
Feb 10, 2031
Rosadoc-20Rosuvastatin (as calcium)
20 mg film coated tabletAlu-Alu Blister Pack of 10's (Box of 30's)
RxVAT-exempt
Rhydburg Pharmaceuticals LtdIndia
Genedrift Philippines Opc
DRP-14130
Feb 10, 2031
RosaltaRosuvastatin (as calcium)
10 mg Film-Coated TabletAlu/Alu Blister Pack x 10's (Box of 30's)
RxVAT-exempt
Lloyd Laboratories, Inc.Philippines
The Cathay YSS Distributors Co., Inc.Trader: Dr. Zen's Research, Inc.
DRP-16418-11
Mar 11, 2030
RosaltaRosuvastatin (as Calcium)
10 mg Film-Coated TabletAlu/Alu Blister Pack x 10's Box of 30's
RxVAT-exempt
Zim Laboratories Ltd.India
The Cathay YSS Distributors Co., Inc.Importer: Ambica International CorporationTrader: Rainbow Life Sciences Pvt. Ltd.
DRP-6002-01
Feb 10, 2030
RosaltaRosuvastatin (as calcium)
10 mg Film-Coated TabletAlu/Alu Blister Pack x 10's (Box of 30's)
RxVAT-exempt
Innova Captab LimitedIndia
The Cathay YSS Distributors Co., IncImporter: Ambica International Corporation
DRP-6405-11
Oct 15, 2030
ROSALTARosuvastatin (as calcium)
20 mg Film-Coated TabletAlu/Alu Blister Pack x 10's (Box of 30's)
RxVAT-exempt
Lloyd Laboratories, Inc.Bulacan
The Cathay YSS Distributors Co.,Inc.Trader: Dr. Zen's Research,Inc.
DRP-16417-02
Mar 11, 2030
RosaltaRosuvastatin (as Calcium)
20 mg Film-Coated TabletAlu-Alu Blister Pack X 10's (Box of 30's)
RxVAT-exempt
Lek S.A.Poland
The Cathay YSS Distributors Co., Inc.Importer: Sandoz Philippines Corporation.
DRP-6489-03
Apr 25, 2030
RosaltaRosuvastatin (as calcium)
20 mg Film-Coated TabletAlu/Alu Blister Pack of 10’s (Box of 30's)
RxVAT-exempt
Stallion Laboratories Pvt. Ltd.India
The Cathay YSS Distributors Co., Inc.Importer: Ambica International Corporation
DRP-8300-08
Aug 7, 2029
RoschlotinRosuvastatin (as calcium)
20 mg Film-Coated TabletAlu/Alu Blister Pack x 10's (Box of 100's)
RxVAT-exempt
Curis Lifesciences Pvt. Ltd.India
Philgen Pharmaceuticals, Inc
DRP-14702
Nov 30, 2028
RosettRosuvastatin (as Calcium)
10 mg Film-Coated TabletAlu/Alu Blister Pack x 10's (Box of 30's)
RxVAT-exempt
Zim Laboratories Ltd.India
Primera Pharma CorporationImporter: Ambica International CorporationTrader: Rainbow Life Sciences Pvt. Ltd.
DRP-6002-02
Feb 10, 2030
RosettRosuvastatin (as calcium)
10 mg Film-Coated TabletAlu/Alu Blister Pack x 10's (Box of 30's)
RxVAT-exempt
Innova Captab LimitedIndia
Primera Pharma CorporationImporter: Ambica International Corporation
DRP-6405-10
Oct 15, 2030
Rosett 20Rosuvastatin (as calcium)
20 mg Film-Coated TabletAlu/Alu Blister Pack of 10's (Box of 30's)
RxVAT-exempt
Stallion Laboratories Pvt. Ltd.India
Primera Pharma CorporationImporter: Ambica International Corporation
DRP-8300-07
Aug 7, 2029
RosgenRosuvastatin (as calcium)
10 mg Film-Coated TabletAlu/Alu Blister Pack x 10's (Box of 30's and 100's)
RxVAT-exempt
Magbro Healthcare Pvt. Ltd.India
Alternative Platform Exchange, Inc.Importer: Teramedix Pharma Trading Inc.
DRP-13727-01
Apr 4, 2028
Rosin 40Rosuvastatin (as calcium)
40 mg Film-coated TabletAlu/Alu Blister Pack x 10's (Box of 100's)
RxVAT-exempt
SunGlow Lifesciences Private LimitedIndia
Despina Pharma Inc.
DRP-15267
Jun 4, 2029
RoslemRosuvastatin (as calcium)
10 mg Film-Coated TabletAlu/Alu Blister Pack x 10’s (Box of 30’s and 100’s)
RxVAT-exempt
Innova Captab Ltd.India
Diafarm Inc.Importer: Ambica International Corporation
DRP-6405-07
Oct 15, 2030
RospecRosuvastatin (as calcium)
10 mg Film-Coated TabletAlu/Alu Blister Pack x 10’s (Box of 100’s)
RxVAT-exempt
Hizon Laboratories, Inc.Philippines
Pharmaspec N.A., Inc.
DRP-6743-01
Mar 30, 2030
RosrichRosuvastatin (as calcium)
10 mg Film-Coated TabletAlu/Alu Blister Pack x 10's (Box of 30's)
RxVAT-exempt
Gracure Pharmaceutical Ltd.India
Medirich Pharma Distribution Corp.Importer: Aglobal Care, Inc.
DRP-16843-01
Jul 16, 2030
Rost 20Rosuvastatin (as calcium)
20 mg Film- Coated TabletAluminum Foil Strip x 10's (Box of 100's)
RxVAT-exempt
Hetero Labs LimitedDistt Solan (H.P.) India
Camber Pharmaceuticals, Inc.
DRP-6822
Sep 16, 2031
RostadRosuvastatin (as Calcium)
10 mg Film-Coated TabletAlu/Alu Blister Pack x 10's (Box of 30's)
RxVAT-exempt
Lek S.A.Poland
Stada Philippines Inc.Importer: Sandoz Philippines Corporation
DRP-6491-03
May 15, 2030
RostadRosuvastatin (as Calcium)
20 mg Film-Coated TabletAlu-Alu Blister Pack X 10's (Box of 30's)
RxVAT-exempt
Lek S.A.Poland
Stada Philippines Inc.Importer: Sandoz Philippines Corporation
DRP-6489-04
Apr 25, 2030
RostanRosuvastatin (as calcium)
10 mg Film-coated TabletAlu/Alu Blister Pack x 10's (Box of 30's)
RxVAT-exempt
Standard Chem. & Pharm. Co., Ltd. (Plant II)China
Standard Chem. & Pharm. Philippines, Inc.
DRP-10174
Apr 26, 2031
RostarRosuvastatin (as Calcium)
20 mg Film-Coated TabletAlu/Alu Blister Pack x 10’s (Box of 30’s)
RxVAT-exempt
PSA Chemicals & Pharmaceuticals Pvt. Ltd.India
TGP Pharma Inc.Importer: Ambica International CorporationTrader: Rainbow Life Sciences Pvt. Ltd.
DRP-15093-07
Apr 23, 2029
RostarRosuvastatin (as calcium)
20 mg Film-Coated TabletAlu/Clear Blister Pack of 10's (Box of 30's)
RxVAT-exempt
Stallion Laboratories Pvt. Ltd.India
TGP Pharma Inc.Importer: Ambica International Corporation
DRP-8300-04
Aug 7, 2029
RostarRosuvastatin (as calcium)
40 mg Film-Coated TabletAlu/Alu Blister Pack x 10's (Box of 30's)
RxVAT-exempt
Sai Parenterals Ltd.India
TGP Pharma Inc.Importer: Nelpa Lifesciences Inc.
DRP-10466-02
Jul 2, 2030
RostarRosuvastatin (as Calcium)
5 mg Film-Coated TabletAlu/Alu Blister Pack x 10’s (Box of 10’s and 30’s)
RxVAT-exempt
Maple Pharmaceuticals (Pvt) LimitedPakistan
TGP Pharma Inc.Importer: Ambica International Corporation
DRP-6651-04
May 20, 2037
Rostatin-20Rosuvastatin (as calcium)
20 mg Film-Coated TabletAlu/Alu Blister Pack x 10's Box of 10’s
RxVAT-exempt
Drug International LimitedBangladesh
Jazmark Pharmaceutical
DRP-7852
Jun 26, 2031
Rostin 20Rosuvastatin (as calcium)
20mg Film-Coated TabletAlu/Alu Blister Pack x 10's (Box of 30's)
RxVAT-exempt
Unison Pharmaceuticals Pvt. LtdIndia
EuroAsia Pharmaceuticals Inc.
DRP-12241
Jun 30, 2032
Rosubest-10Rosuvastatin (as calcium)
10 mg Film-Coated TabletAlu/Alu Blister Pack x 10's (Box of 100's)
RxVAT-exempt
Gracure Pharmaceutical Ltd.India
One Technodrug Life Sciences Inc.Importer: Sanimed Pharmaceuticals Inc.
DRP-14693-02
Nov 28, 2028
Rosubest-20Rosuvastatin (as calcium)
20 mg Film-Coated TabletAlu/Alu Blister Pack x 10's (Box of 100's)
RxVAT-exempt
Gracure Pharmaceutical Ltd.India
One Technodrug Life Sciences Inc.Importer: Sanimed Pharmaceuticals Inc.
DRP-14694-02
Nov 28, 2028
Rosubet-10Rosuvastatin (as calcium)
10 mg Film-Coated TabletAlu/Alu Blister Pack x 10's (Box of 30's)
RxVAT-exempt
Umedica Laboratories Pvt. Ltd.India
Better Option Pharmaceuticals, Inc.Importer: Suhitas Pharmaceuticals Inc.
DRP-9314-01
Oct 17, 2031
Rosubet-20Rosuvastatin (as calcium)
20 mg Film-Coated TabletAlu-Alu Blister Pack x 10's (Box of 30's)
RxVAT-exempt
Umedica Laboratories Pvt. Ltd.India
Better Option Pharmaceuticals, Inc.Importer: Suhitas Pharmaceuticals Inc.
DRP-9315-01
Sep 11, 2031
Rosubet-40Rosuvastatin (as calcium)
40 mg Film-Coated TabletAlu/Alu Blister Pack x 10's (Box of 30's)
RxVAT-exempt
Umedica Laboratories Pvt. Ltd.India
Better Option Pharmaceuticals, Inc.Importer: Suhitas Pharmaceuticals Inc.
DRP-9478-02
Oct 25, 2031
Rosubolic-10Rosuvastatin (as calcium)
10 mg Film-Coated TabletAlu/Alu Blister Pack x 10's (Box of 30's and 100's)
RxVAT-exempt
Innova Captab LimitedIndia
Ambica International Corporation
DRP-6405
Oct 15, 2030
RosucareRosuvastatin (as Calcium)
10 mg Film-Coated TabletAlu/Alu Blister Pack x 10's (Box of 30's)
RxVAT-exempt
Zim Laboratories Ltd.India
North Care Pharmaceutical DistributorshipImporter: Ambica International CorporationTrader: Rainbow Life Sciences Pvt. Ltd.
DRP-6002-04
Feb 10, 2030
RosucassRosuvastatin (as calcium)
10 mg Film-Coated TabletAlu/Alu Blister Pack x 10's (Box of 30's and Box of 100's)
RxVAT-exempt
Gracure Pharmaceutical Ltd.India
Cassandras Care Pharmaceutical DistributorImporter: Dreamax Incorporated
DRP-8706-03
Feb 24, 2031
RosucassRosuvastatin (as calcium)
20 mg Film-Coated TabletAlu/Alu Blister Pack x 10's (Box of 30's)
RxVAT-exempt
Gracure Pharmaceutical Ltd.India
Cassandras Care Pharmaceutical DistributorImporter: Dreamax Incorporated
DRP-8705-03
Feb 9, 2037
RosucheRosuvastatin (as Calcium)
20 mg Film-Coated TabletAlu/Alu Blister Pack x 10's (Box of 30's and 100's)
RxVAT-exempt
Gracure Pharmaceutical Ltd.India
Trisixteen Pharmaceutical Products TradingImporter: Aglobal Care, Inc.
DRP-8482-02
Jan 15, 2029
RosucoaRosuvastatin
10 mg Film-Coated TabletAlu/Alu Blister Pack x 10's (Box of 30's and 100's)
RxVAT-exempt
Hebei Tiancheng Pharmaceutical Co., Ltd.China
AMB HK Enterprises Inc.
DRP-16671
Jun 10, 2030
RosucoaRosuvastatin
20 mg TabletAlu/Alu Blister Pack x 10's (Box of 30's and 100's)
RxVAT-exempt
Hebei Tiancheng Pharmaceutical Co., Ltd.China
AMB HK Enterprises Inc.
DRP-16670
Jun 10, 2030
RosucoaRosuvastatin
40 mg TabletAlu/Alu Blister Pack x 10's (Box of 30's and 100's)
RxVAT-exempt
Hebei Tiancheng Pharmaceutical Co., Ltd.China
AMB HK Enterprises Inc.
DRP-16669
Jun 10, 2030
RosucoaRosuvastatin
5 mg Film-Coated TabletAlu/Alu Blister Pack x 10's (Box of 30's and 100's)
RxVAT-exempt
Hebei Tiancheng Pharmaceutical Co., Ltd.China
AMB HK Enterprises Inc.
DRP-16672
Jun 10, 2030
RosucolRosuvastatin (as calcium)
10 mg Film-Coated TabletAlu/Alu Blister Pack x 10's (Box of 30's)
RxVAT-exempt
Ajanta Pharma LimitedIndia
Ajanta Pharma Philippines Inc.Importer: Ajanta Pharma Philippines Inc..
DR-XY47902
Apr 5, 2027
RosucolRosuvastatin (as Calcium)
10mg Film-Coated TabletAlu/Alu blister pack x 10's (Box of 30's)
RxVAT-exempt
Ajanta Pharma Ltd.India
Ajanta Pharma Philippines, Inc.
DR-XY41930
Dec 12, 2027
RosucolRosuvastatin (as calcium)
20 mg Film-Coated TabletAlu/Alu Blister Pack x 10's (Box of 30's)
RxVAT-exempt
Ajanta Pharma LimitedIndia
Ajanta Pharma Philippines Inc.Importer: Ajanta Pharma Philippines Inc..
DR-XY47901
Apr 5, 2027
RosucolRosuvastatin (as Calcium)
20 mg Film-Coated TabletAlu/Alu Blister Pack x 10's (Box of 30's)
RxVAT-exempt
Ajanta Pharma LimitedIndia
Ajanta Pharma Philippines, Inc.
DRP-2065
Jul 29, 2029
RosucolRosuvastatin (as calcium)
5 mg Film-Coated TabletAlu/Alu Blister Pack x 10's (Box of 30's)
RxVAT-exempt
Ajanta Pharma Ltd.India
Ajanta Pharma Philippines, Inc.Importer: Ajanta Pharma Philippines Inc..
DR-XY39607
May 30, 2029
RosucolRosuvastatin (as calcium)
5 mg Film-Coated TabletAlu/Alu Blister Pack x 10's (Box of 30's)
RxVAT-exempt
Ajanta Pharma LimitedIndia
Ajanta Pharma Philippines IncImporter: Ajanta Pharma Philippines Inc..
DR-XY48136
Jun 27, 2027
Rosucres-10Rosuvastatin (as calcium)
10 mg Film-Coated TabletAlu/Alu Blister Pack x 10's (Box of 30's)
RxVAT-exempt
Umedica Laboratories Pvt. Ltd.India
HLM Pharmaceutical Inc.Importer: Suhitas Pharmaceuticals Inc.
DRP-9314-03
Oct 17, 2031
Rosucres-20Rosuvastatin (as calcium)
20 mg Film-Coated TabletAlu/Alu Blister Pack x 10's (Box of 30's)
RxVAT-exempt
Umedica Laboratories Pvt. Ltd.India
HLM Pharmaceutical Inc.Importer: Suhitas Pharmaceuticals Inc.
DRP-9315-04
Sep 11, 2031
RosucuraRosuvastatin (as calcium)
10 mg Film-Coated TabletAlu/Alu Blister Pack x 10's (Box of 30's)
RxVAT-exempt
Umedica Laboratories Pvt. Ltd.India
RVM Pharma & Medical Supplies DistributionImporter: Suhitas Pharmaceuticals Inc.
DRP-9314-07
Sep 4, 2031
RosucuraRosuvastatin (as calcium)
20 mg Film-Coated TabletAlu/Alu Blister Pack x 10's (Box of 30's)
RxVAT-exempt
Umedica Laboratories Pvt. Ltd.India
RVM Pharma & Medical Supplies DistributionImporter: Suhitas Pharmaceuticals Inc.
DRP-9315-07
Aug 17, 2031
RosucureRosuvastatin (as Calcium)
10 mg Film-coated TabletAlu/Alu Blister Pack x 10's (Box of 30's, 50's & 100's)
RxVAT-exempt
Azarias Pharmaceutical Laboratories Inc.Philippines
Jaac Healthline Marketing
DRP-16595-02
May 13, 2030
RosucureRosuvastatin (as Calcium)
20 mg Film-Coated TabletAlu/Alu Blister Pack x 10's (Box of 30's, 50's and 100's)
RxVAT-exempt
Azarias Pharmaceutical Laboratories Inc.Philippines
Jaac Healthline Marketing
DRP-16586-02
May 8, 2030
Rosudaise 10Rosuvastatin (as Calcium)
10 mg Film-Coated TabletAlu/Alu Blister Pack x 10's (Box of 30')
RxVAT-exempt
Innova Captab LimitedIndia
RoDaise Pharma Distributor CorporationImporter: Ambica International Corporation
DRP-6405-04
Oct 15, 2030
Rosudaise 20Rosuvastatin (as calcium)
20 mg Film-Coated TabletAlu/Alu blister pack of 10's (Box of 30's)
RxVAT-exempt
Stallion Laboratories Pvt. Ltd.India
RoDaise Pharma Distributor CorporationImporter: Ambica International Corporation
DRP-8300-10
Aug 7, 2029
RosudexRosuvastatin (as Calcium)
20 mg Film-Coated TabletAlu/Alu Foil Strip Pack x 10's (Box of 30's)
RxVAT-exempt
PT Dexa MedicaIndonesia
Glorious Dexa Mandaya, Inc.
DRP-13307
Jan 24, 2028
Rosufar-20Rosuvastatin (as calcium)
20 mg Film-Coated TabletAlu/Alu Blister Pack x 10's Box of 30's
RxVAT-exempt
Zim Laboratories LimitedIndia
Pharmakon Biotec Inc.
DRP-9029
Aug 18, 2030
Rosufed-20Rosuvastatin (as Calcium)
20 mg Film-Coated TabletAlu-Alu Blister Pack x 10's (Box of 30's and 100's)
RxVAT-exempt
PSA Chemicals & Pharmaceuticals Pvt. Ltd.India
Ambitech Biopharmaceuticals Inc.Importer: Ambica International CorporationTrader: Rainbow Life Sciences Pvt. Ltd.
DRP-15093-06
Apr 23, 2029
RosuferRosuvastatin (as calcium)
20 mg Film-Coated TabletAlu / Alu Blister Pack x 10's (Box of 30's, 50's and 100's)
RxVAT-exempt
Azarias Pharmaceutical Laboratories, Inc.Philippines
Ferma Drug Enterprises
DRP-16586-03
May 8, 2030
RosufirstRosuvastatin (As Calcium)
10 mg Film-Coated TabletAlu-Alu Blister Pack X 10's (Box of 30's)
RxVAT-exempt
J.M. Tolmann Laboratories Inc.Philippines
Firstmed Theraconcept Inc.
DRP-7114
May 11, 2031
Rosugold-10Rosuvastatin (as Calcium)
10 mg Film-coated TabletAlu/Alu Blister Pack x 10's (Box of 30's, 50's & 100's)
RxVAT-exempt
Azarias Pharmaceutical Laboratories Inc.Philippines
Brilliantmeed, Inc.
DRP-16595-06
May 13, 2030
Rosugold-20Rosuvastatin (as Calcium)
20 mg Film-Coated TabletAlu/Alu Blister Pack x 10's (Box of 30's, 50's and 100's)
RxVAT-exempt
AZARIAS PHARMACEUTICAL LABORATORIES INC.Philippines
Brilliantmeed, Inc.
DRP-16586-07
May 8, 2030
Rosugrand-10Rosuvastatin(as Calcium)
10mg Film-Coated TabletAlu-Alu blister pack x 10's (Box of 100's); Alu-Alu blister pack x 10's (Box of 30's)
RxVAT-exempt
Magbro Healthcare Pvt. Ltd.India
Grandis Pharma IncorporatedImporter: Teramedix Pharma Trading Inc.
DRP-13727-10
Apr 4, 2028
Rosugrand-20Rosuvastatin (as calcium)
20 mg TabletAlu-Alu blister pack x 10`s (Box of 30's and 100's)
RxVAT-exempt
Magbro Healthcare Pvt. Ltd.India
Grandis Pharma IncorporatedImporter: Teramedix Pharma Trading Inc
DRP-9986-08
Jul 8, 2031
RosukonRosuvastatin (as calcium)
10 mg Film-Coated TabletAlu/Alu Blister Pack x 10's (Box of 100's)
RxVAT-exempt
Magbro Healthcare Pvt. Ltd.India
Pharmakon Biotec Inc.
DRP-14226
Oct 28, 2027
Rosukon-10Rosuvastatin (as calcium)
10 mg Film-Coated TabletAlu/Alu Blister Pack x 10's (Box of 100's)
RxVAT-exempt
Magbro Healthcare Pvt. Ltd.India
Pharmakon Biotec Inc.
DR-XY48444
Oct 28, 2027
Rosukon-20Rosuvastatin (as calcium)
20 mg TabletAlu/Alu Blister Pack x 10's (Box of 30's)
RxVAT-exempt
Magbro Healthcare Pvt. Ltd.India
Labmate Pharma Inc.Importer: Pharmakon Biotec Inc.
DRP-10077
Oct 6, 2030
Rosulip-10Rosuvastatin (as calcium)
10 mg Film-Coated TabletAlu/Alu Blister Pack x 10‘s (Box of 30’s)
RxVAT-exempt
Umedica Laboratories Pvt. Ltd.India
Suhitas Pharmaceuticals Inc.
DRP- 9314
Nov 25, 2030
Rosulip-20Rosuvastatin (as calcium)
20 mg Film-Coated TabletAlu/Alu Blister Pack x 10‘s (Box of 30’s)
RxVAT-exempt
Umedica Laboratories Pvt. Ltd.India
Suhitas Pharmaceuticals Inc.
DRP-9315
Nov 25, 2030
Rosulip-40Rosuvastatin (as calcium)
40 mg Film-Coated TabletAlu/Alu Blister Pack x 10’s (Box of 30's)
RxVAT-exempt
Umedica Laboratories Pvt. Ltd.India
Suhitas Pharmaceuticals, Inc.
DRP-9478
Oct 25, 2031
Rosumax-10Rosuvastatin (as calcium)
10 mg Film-Coated TabletAlu/Alu Blister Pack x 10's (Box of 30's and 100's)
RxVAT-exempt
Gracure Pharmaceutical Ltd.India
Gijun Trading Inc.Importer: Dreamax Incorporated
DRP-8706
Feb 7, 2030
Rosumax-20Rosuvastatin (as calcium)
20 mg Film-Coated TabletAlu/Alu Blister Pack x 10's (Box of 30's and 100's)
RxVAT-exempt
Gracure Pharmaceutical Ltd.India
Dreamax Incorporated
DRP-8705
Feb 7, 2030
RosumondRosuvastatin (as Calcium)
10 mg TabletAluminum Foil Strip by 4's (Box of 100's)
RxVAT-exempt
Diamond Laboratories, IncPhilippines
Rilem Pharma Corp.
DRP-7609
Jan 11, 2031
RosumondRosuvastatin (as calcium)
5 mg TabletAluminum Strip Foil x 4's (Box of 100's)
RxVAT-exempt
Diamond Laboratories, Inc.Philippines
—
DRP-7608
Aug 11, 2031
RosunavRosuvastatin (as Calcium)
10 mg Film-Coated TabletAlu/Alu Blister Pack x 10's (Box of 10's) and (Box of 1's) as Physician's Sample
RxVAT-exempt
Pharmevo (Pvt) LimitedPakistan
Rexmed Pharmaceutical SalesImporter: Accesspoint International Trading Inc.
DRP-12702-02
Apr 5, 2037
RosunavRosuvastatin
20 mg Film-coated TabletAlu/Alu Blister Pack x 10's (Box of 100's)
RxVAT-exempt
Medisure Laboratories Pakistan (Pvt.) Ltd.Pakistan
Rexmed Pharmaceutical SalesImporter: Accesspoint International Trading Inc.
DRP-17639-02
Feb 10, 2031
RosunisRosuvastatin (as calcium)
20mg Film-Coated TabletAlu/Alu Blister Pack x 10's (Box of 30's)
RxVAT-exempt
Magbro Healthcare Pvt. Ltd.India
Curasave PharmaImporter: Pharmakon Biotec Inc.
DRP-10077-02
Oct 6, 2030
Rosunovtin-20Rosuvastatin Calcium
20mg Film-Coated TabletAlu-Alu Blister x 10’s (Box of 30’s and 100’s)
RxVAT-exempt
Salud Care (India) LimitedIndia
Medinova Pharmaceutical Inc.
DRP-19140
Nov 5, 2031
RosuphilRosuvastatin (as Calcium)
10 mg Film-Coated TabletAlu/Alu Blister Pack x 10's (Box of 30's)
RxVAT-exempt
Zim Laboratories Ltd.India
Phil Asia Pharma Inc.Importer: Ambica International CorporationTrader: Rainbow Life Sciences Pvt. Ltd.
DRP-6002-05
Feb 10, 2030
RosuphilRosuvastatin (as calcium)
10 mg Film-Coated TabletAlu/Alu Blister Pack x 10's (Box of 30's and 100's)
RxVAT-exempt
Innova Captab LimitedIndia
Phil Asia Pharma IncImporter: Ambica International Corporation
DRP-6405-09
Oct 15, 2030
Rosuphili 20Rosuvastatin (as calcium)
20 mg TabletAlu/Alu Blister Pack x 10's (Box of 30's)
RxVAT-exempt
Magbro Healthcare Pvt. Ltd.India
Teramedix Pharma Trading Inc.Importer: Pharmakon Biotec Inc.
DRP-10077-10
Oct 6, 2030
Rosuple 10Rosuvastatin (As Calcium)
10 mg Film-Coated TabletAlu/Alu Blister Pack x 10's (Box of 10's and 100's)
RxVAT-exempt
Maple Pharmaceuticals (Pvt.) Ltd.Pakistan
Ambica International Corporation
DRP-6650
Apr 22, 2031
Rosuple 5Rosuvastatin (as Calcium)
5 mg Film-Coated TabletAlu/Alu Blister Pack x 10’s (Box of 10’s and 30’s)
RxVAT-exempt
Maple Pharmaceuticals (Pvt) LimitedPakistan
Ambica International Corporation
DRP-6651
Apr 22, 2037
RosuppexRosuvastatin (as calcium)
10 mg Film-Coated TabletAlu - Alu Blister Pack X 10's (Box of 30's)
RxVAT-exempt
J.M. Tolmann Laboratories IncPhilippines
Appex MD's Pharmaceutical Inc
DRP-7114-01
May 25, 2031
Rosusaph-10Rosuvastatin (as calcium)
10 mg Film-Coated TabletAlu/Alu Blister Pack x 10's (Box of 30's and 100's)
RxVAT-exempt
Sai Parenterals Ltd.India
Nelpa Lifesciences, Inc.
DRP-11330
Jul 2, 2030
Rosusaph-20Rosuvastatin (as calcium)
20 mg Film-Coated TabletAlu/Alu Blister Pack x 10's (Box of 30's)
RxVAT-exempt
Sai Parenterals Ltd.India
Nelpa Lifesciences Inc.
DRP-10467
Jul 2, 2030
Rosusaph-40Rosuvastatin (as calcium)
40 mg Film-Coated TabletAlu/Alu Blister Pack x 10's (Box of 30's)
RxVAT-exempt
Sai Parenterals Ltd.India
Nelpa Lifesciences Inc.
DRP-10466
Jul 2, 2030
RosuSaveRosuvastatin
20 mg Film-coated TabletAlu/Alu Blister Pack x 10's (Box of 100's)
RxVAT-exempt
Medisure Laboratories Pakistan (Pvt.) Ltd.Pakistan
Savelink Pharma and Trading Co.Importer: Accesspoint International Trading Inc.
DRP-17639-01
Feb 10, 2031
RosuSAVERosuvastatin (as Calcium)
20 mg Film-Coated TabletAlu/Alu Blister Pack x 10's (Box of 100's)
RxVAT-exempt
Gracure Pharmaceuticals LimitedIndia
Savelink Pharma And Trading Co.Importer: Aglobal Care, Inc.
DRP-8482-04
Jan 15, 2029
RosuSaveRosuvastatin
40 mg Film-coated TabletAlu/Alu Blister Pack x 10's (Box of 100's)
RxVAT-exempt
Medisure Laboratories Pakistan (Pvt.) LimitedPakistan
Savelink Pharma and Trading Co.Importer: Accesspoint International Trading Inc.
DRP-17515-02
Jan 16, 2031
RosustanRosuvastatin (as calcium)
10 mg Film-Coated TabletAlu-Alu Blister Pack X 10's (Box of 30's)
RxVAT-exempt
J.M. Tolmann Laboratories, Inc.Philippines
Westfield Pharmaceuticals, Inc.
DRP-7114-03
May 11, 2031
RosustatRosuvastatin Calcium
10 mg Film-Coated TabletAlu/Alu Blister Pack x 10's (Box of 30's)
RxVAT-exempt
Lloyd Laboratories, Inc.Philippines
Trader: Justright Healthcare Inc.
DR-XY44198
Feb 23, 2030
RosustatRosuvastatin Calcium
20 mg Film-Coated TabletAlu/Alu Blister Pack x 10's (Box of 30's)
RxVAT-exempt
Lloyd Laboratories, Inc.Philippines
Justright Healthcare Inc.Trader: Euro-Health Care Exponents, Inc.
DRP-8108-02
Feb 11, 2030
Rosustat®10Rosuvastatin (as calcium)
10 mg Film-Coated TabletAlu/Alu Blister Pack x 10's (Box of 30's)
RxVAT-exempt
Lloyd Laboratories, IncPhilippines
Justright Healthcare, Inc.Trader: Dr. Zen's Research, Inc.
DRP-16418-02
Mar 11, 2030
Rosustat®20Rosuvastatin (as calcium)
20 mg Film-Coated TabletAlu/Alu Blister Pack x 10's (Box of 30's)
RxVAT-exempt
Lloyd Laboratories, Inc.Philippines
Justright Healthcare Inc.Trader: Dr. Zen's Research, Inc.
DRP-16417-01
Mar 11, 2030
RosutechRosuvastatin (as calcium)
10 mg Film-Coated TabletAlu/Alu Blister Pack x 10's (Box of 100's)
RxVAT-exempt
Fredun Pharmaceuticals LimitedIndia
SNV Biotech Medicinal Products WholesalingImporter: AMB HK Enterprises Inc.
DRP-12201-02
Jun 29, 2027
RosutechRosuvastatin (as calcium)
20 mg Film-Coated TabletAlu/Alu Blister Pack x 10's (Box of 100's)
RxVAT-exempt
Fredun Pharmaceuticals LimitedIndia
SNV Biotech Medicinal Products WholesalingImporter: AMB HK Enterprises Inc.
DRP-12200-01
Jun 29, 2027
RosuteraRosuvastatin (as calcium)
10 mg Film-Coated TabletAlu/Alu Blister Pack x 10’s (Box of 30’s)
RxVAT-exempt
Umedica Laboratories Pvt. Ltd.India
Reta DrugImporter: Suhitas Pharmaceuticals Inc.
DRP-9314-08
Nov 25, 2030
RosuuRosuvastatin (as calcium)
10mg Film Coated TabletAlu/Alu Blister Pack x 10's (Box of 100's)
RxVAT-exempt
Fredun Pharmaceuticals Limited.India
AMB HK Enterprises Inc.
DRP-14845
Jan 23, 2029
RosuuRosuvastatin (as calcium)
20mg Film-Coated TabletAlu/Alu Blister Pack x 10's (Box of 100's)
RxVAT-exempt
Fredun Pharmaceuticals Limited.India
AMB HK Enterprises Inc.
DRP-14844
Jan 23, 2029
RosuuRosuvastatin (as calcium)
5mg Film Coated TabletAlu/Alu Blister Pack x 10's (Box of 100's)
RxVAT-exempt
Fredun Pharmaceuticals Limited.India
AMB HK Enterprises Inc.
DRP-14846
Jan 23, 2029
Rosuvalife 10Rosuvastatin (as calcium)
10 mg Film Coated TabletAlu/Alu Blister Pack x 10's (Box of 30's, 60's, 90's and 100's)
RxVAT-exempt
Flourish PharmaIndia
Biophil Medical Equipment and Supplies Trading
DRP-17315
Nov 13, 2030
Rosuvalife 20Rosuvastatin (as calcium)
20 mg Film Coated TabletAlu/Alu Blister Pack x 10's (Box of 30's, 60's, 90's and 100's)
RxVAT-exempt
Flourish PharmaIndia
Biophil Medical Equipment and Supplies Trading
DRP-17316
Nov 13, 2030
RosuvaproRosuvastatin (as calcium)
10 mg Film-Coated TabletAlu/Alu Blister Pack x 10's (Box of 100's)
RxVAT-exempt
Magbro Healthcare Pvt. Ltd.India
Pharma Hub CorporationImporter: Pharmakon Biotec Inc.
DRP-14226-02
Oct 28, 2027
RosuvaproRosuvastatin (as calcium)
20mg Film-Coated TabletAlu/Alu Blister Pack x 10's (Box of 30's)
RxVAT-exempt
Magbro Healthcare Pvt. Ltd.India
Pharma Hub CorporationImporter: Pharmakon Biotec Inc.
DRP-10077-06
Oct 6, 2030
RosuvasureRosuvastatin
20 mg Film-coated Tablet
RxVAT-exempt
Medisure Laboratories Pakistan (Pvt.) Ltd.Pakistan
Accesspoint International Trading Inc.
DRP-17639
Feb 10, 2031
RosuvasureRosuvastatin
40 mg Film-coated TabletAlu/Alu Blister Pack x 10's (Box of 30's)
RxVAT-exempt
Medisure Laboratories Pakistan (Pvt.) Ltd.Pakistan
Accesspoint International Trading Inc.
DRP-17515
Jan 16, 2031
Rosuvate-20Rosuvastatin (as Calcium)
20 mg Film-Coated TabletAlu / Alu Blister Pack x 10's (Box of 30's)
RxVAT-exempt
Gracure Pharmaceutical Ltd.India
K Pharma Medical Corp.Importer: AGlobal Care, Inc.
DRP-8482-03
Jan 15, 2029
RosuvaxRosuvastatin (as calcium)
20 mg Film-Coated TabletAlu/Alu Blister Pack x 10's (Box of 30's)
RxVAT-exempt
Gracure Pharmaceutical Ltd.India
CSP Lifesciences Philippines Inc.
DRP-17857
Mar 25, 2032
RosuvazRosuvastatin (as calcium)
10 mg Film-Coated TabletAlu/Alu Blister Pack x 10's (Box of 30's)
RxVAT-exempt
Lloyd Laboratories, Inc.Philippines
Trader: Ultramed Pharma, Inc.
DR-XY36781
Apr 5, 2031
RosuvazRosuvastatin (as calcium)
20 mg Film-Coated TabletAlu/Alu Blister Pack x 10's (Box of 30's)
RxVAT-exempt
Lloyd Laboratories, Inc.Philippines
Trader: Ultramed Pharma, Inc.
DRP-8111
Apr 5, 2031
Rosuvazet 10Rosuvastatin (as calcium)
10 mg Film-Coated TabletAlu/Alu Blister Pack x 10’s (Box of 30’s and 100’s)
RxVAT-exempt
Sai Parenterals LtdIndia
Roymed PharmaceuticalImporter: Nelpa Lifesciences, Inc.
DRP-11330-03
Jul 2, 2030
Rosuvazt-10Rosuvastatin Calcium
10mg Film-Coated TabletAlu/Alu blister x 10’s (Box of 30's and 100’s)
RxVAT-exempt
Salud Care (India) LimitedIndia
Medinova Pharmaceutical Inc.
DRP-19141
Nov 5, 2031
RosuvelRosuvastatin
10 mg Film Coated Tablet
RxVAT-exempt
Reyoung Pharmaceutical Co., Ltd.China
AMB HK Enterprises Inc.
DRP-17537
Feb 6, 2031
RosuvelRosuvastatin
20 mg Film Coated Tablet
RxVAT-exempt
Reyoung Pharmaceutical Co., Ltd.China
AMB HK Enterprises Inc.
DRP-17533
Feb 6, 2031
RosuvelRosuvastatin
40 mg Film Coated Tablet
RxVAT-exempt
Reyoung Pharmaceutical Co., Ltd.China
AMB HK Enterprises Inc.
DRP-17534
Feb 6, 2031
RosuvelRosuvastatin
5 mg Film Coated Tablet
RxVAT-exempt
Reyoung Pharmaceutical Co., Ltd.China
AMB HK Enterprises Inc.
DRP-17536
Feb 6, 2031
Rosuvin 10Rosuvastatin (as Calcium)
10 mg Film-Coated TabletAlu-Alu Blister Pack x 10's (Box of 30's)
RxVAT-exempt
PSA Chemicals & Pharmaceuticals Pvt. Ltd.India
Ambica InternationalImporter: Ambica International CorporationTrader: Rainbow Life Sciences Pvt.
DRP-15849
Sep 23, 2029
Rosuvin 10Rosuvastatin (as Calcium)
10 mg Film-Coated TabletAlu/Alu Blister Pack x 10's (Box of 30's)
RxVAT-exempt
Zim Laboratories Ltd.India
Cyden Medicale Trading Inc.Importer: Ambica International CorporationTrader: Rainbow Life Sciences Pvt. Ltd.
DRP-6002
Feb 10, 2030
Rosuvin 20Rosuvastatin (as Calcium)
20 mg Film-Coated TabletAlu-Alu Blister Pack x 10's (Box of 30's)
RxVAT-exempt
PSA Chemicals & Pharmaceuticals Pvt. Ltd.India
Ambica International CorporationTrader: Rainbow Life Sciences Pvt. Ltd.
DRP-15093
Apr 23, 2029
RosuvraRosuvastatin (as calcium)
10 mg Film-Coated TabletAlu/Alu Blister Pack x 10's (Box of 30's)
RxVAT-exempt
Gracure Pharmaceutical Ltd.301019 India
TGP Pharma Inc.Importer: AGlobal Care, Inc.
DRP-16843-02
Jul 16, 2030
Rosuxl 20Rosuvastatin (as calcium)
20 mg Film-Coated TabletAlu/Alu Blister Pack x 10's (Box of 30's and 100's)
RxVAT-exempt
XL Laboratories Pvt. Ltd.India
Ambica International Corporation
DRP-11183
Feb 11, 2032
RosuzanRosuvastatin (as Calcium)
20 mg Film-Coated TabletAlu/Alu Blister Pack x 10's (Box of 30's, 50's and 100's)
RxVAT-exempt
Azarias Pharmaceutical Laboratories Inc.Philippines
Triple 888 Medical And Pharma Inc.
DRP-16586-01
May 8, 2030
Rosuzan-10Rosuvastatin (as Calcium)
10 mg Film-Coated TabletAlu/Alu Blister Pack x 10's (Box of 30's, 50's & 100's)
RxVAT-exempt
Azarias Pharmaceutical Laboratories Inc.Philippines
Triple 888 Medical And Pharma Inc.
DRP-16595-01
May 13, 2030
Rosva 10Rosuvastatin (as Calcium)
10mg Film-Coated TabletAlu/Alu Blister Pack x 10's (Box of 30's)
RxVAT-exempt
Inventia Healthcare LimitedIndia
Orange Biotec Inc.
DRP-14277
Aug 9, 2028
Rosva 20Rosuvastatin (as Calcium)
20 mg Film-Coated TabletsAlu/Alu Blister Pack x 10's (Box of 30's)
RxVAT-exempt
Inventia Healthcare LimitedIndia
Orange Biotec Inc.
DRP-14276
Aug 9, 2028
Rosva 40Rosuvastatin (as Calcium)
40 mg Film-Coated TabletsAlu/Alu Blister Pack x 10's (Box of 30's)
RxVAT-exempt
Inventia Healthcare LimitedIndia
Orange Biotec Inc.
DRP-14273
Aug 9, 2028
Rosva 5Rosuvastatin (as Calcium)
5 mg Film-Coated TabletAlu/Alu Blister Pack x 10's (Box of 30's)
RxVAT-exempt
Inventia Healthcare LimitedIndia
Orange Biotec Inc.
DRP-16490
Apr 15, 2030
RosvascalRosuvastatin (as Calcium)
10 mg Film-Coated TabletAlu/Alu Blister Pack x 10's (Box of 30's)
RxVAT-exempt
Zim Laboratories Ltd.India
K Pharma Medical Corp.Importer: Ambica International CorporationTrader: Rainbow Life Sciences Pvt. Ltd.
DRP-6002-07
Feb 10, 2030
RosvascalRosuvastatin (as calcium)
10 mg Film-Coated TabletAlu/Alu Blister Pack x 10's (Box of 30's)
RxVAT-exempt
Innova Captab LimitedIndia
K Pharma Medical Corp.Importer: Ambica International Corporation
DRP-6405-08
Oct 15, 2030
RosvastiumRosuvastatin (as Calcium)
5 mg Film-Coated TabletAlu/Alu Blister Pack x 10’s (Box of 10’s)
RxVAT-exempt
Maple Pharmaceuticals (Pvt.) Ltd.Pakistan
Ambicare Pharmaceuticals Inc.Importer: Ambica International Corporation
DRP-6651-02
Jul 24, 2037
RosveraRosuvastatin (As Calcium)
20 mg Film-Coated TabletAlu/Alu Blister Pack X 10’s (Box of 30's, 60's and 100's)
RxVAT-exempt
Gracure Pharmaceutical Ltd.India
Epione Lifecare Inc.Importer: Despina Pharma Inc.
DRP-15767-01
Sep 12, 2029
RoswinRosuvastatin (as calcium)
10 mg Film-Coated TabletAlu/Alu Blister Pack x 10's (Box of 30's)
RxVAT-exempt
Amherst Laboratories, Inc.Philippines
Trader: UNILAB, Inc.
DR-XY44819
Sep 4, 2030
RoswinRosuvastatin (as calcium)
10 mg Film-Coated TabletAlu/Alu Foil Strip x 10's (Box of 30's)
RxVAT-exempt
Ajanta Pharma Ltd.India
UNILAB, Inc.
DRP-10102
Jul 22, 2031
RoswinRosuvastatin (as calcium)
10 mg Film-Coated TabletAlu/Alu Blister Pack x 10's (Box of 30's)
RxVAT-exempt
Amherst Laboratories, Inc.Philippines
Trader: UNILAB, Inc.
DRP-9537
Mar 3, 2031
RoswinRosuvastatin (as calcium)
20 mg Film-Coated TabletAlu/Alu Blister Pack x 10's (Box of 30's)
RxVAT-exempt
Amherst Laboratories, Inc.Philippines
Trader: UNILAB, Inc.
DR-XY44820
Sep 4, 2030
RoswinRosuvastatin (as Calcium)
20 mg Film-Coated TabletAlu-Alu Blister Pack x 10's (Box of 30's)
RxVAT-exempt
AJANTA PHARMA LIMITEDIndia
UNILAB, INC.Importer: AJANTA PHARMA PHILIPPINES
DRP-2065-01
Jul 29, 2029
RoswinRosuvastatin (as calcium)
20 mg Film-Coated TabletAlu/Alu Blister Pack x 10's (Box of 30's)
RxVAT-exempt
Amherst Laboratories, Inc.Philippines
Trader: UNILAB, Inc.
DRP-9536
Mar 3, 2031
RoswinRosuvastatin (as calcium)
5 mg Film-Coated TabletAlu/Alu Blister Pack x 10's (Box of 30's)
RxVAT-exempt
Amherst Laboratories, Inc.Philippines
Trader: UNILAB, Inc.
DR-XY44818
Sep 4, 2030
RoswinRosuvastatin (as calcium)
5 mg Film-Coated TabletAlu/Alu Foil Strip x 10's (Box of 30's)
RxVAT-exempt
Ajanta Pharma LimitedIndia
Unilab, Inc.
DRP-11653
Jan 21, 2030
RotsercRosuvastatin (as Calcium)
20 mg Film-Coated TabletAlu-Alu Blister Pack x 10's (Box of 30's and 100's)
RxVAT-exempt
PSA Chemicals & Pharmaceuticals Pvt. Ltd.India
Ambitech Biopharmaceuticals Inc.Importer: Ambica International CorporationTrader: Rainbow Life Sciences Pvt. Ltd.
DRP-15093-05
Apr 23, 2029
Rovas 10Rosuvastatin (as calcium)
10 mg Film-Coated TabletAlu/Alu Blister Pack x 10's (Box of 30's)
RxVAT-exempt
Unison Pharmaceuticals Private LimitedIndia
PH Phil Asia Medica Co.
DRP-16924
Sep 2, 2031
RovastRosuvastatin (as calcium)
20 mg Film-Coated TabletAluminum Strip Foil x 10's Box of 100's
RxVAT-exempt
Hizon Laboratories, Inc.Philippines
Sigmamatic Co., Inc.
DRP-1762
Jul 9, 2029
Rovastatin 40Rosuvastatin
40 mg Film-Coated TabletAlu/Alu Blister Pack x 10's (Box of 100's)
RxVAT-exempt
Curis Lifesciences Pvt. Ltd.India
Philgen Pharmaceuticals, Inc.
DRP-14701
Nov 30, 2028
RovastinRosuvastatin (as calcium)
10 mg Film-Coated TabletAlu/Alu Blister Pack x 10's (Box of 100's)
RxVAT-exempt
Hizon Laboratories, Inc.Philippines
GX International, Inc.
DRP-6743-02
Mar 30, 2030
RovastinRosuvastatin (as calcium)
20 mg Film-Coated TabletOPA/Alu/PVC/Alu Blister Pack x 10's (Box of 100's)
RxVAT-exempt
Hizon Laboratories, Inc.Philippines
Trader: GX International, Inc.
DR-XY48975
Jan 11, 2029
RovastinRosuvastatin (as calcium)
20 mg Film-Coated TabletOPA/Alu/PVC/Alu Blister Pack x 10's (Box of 100's)
RxVAT-exempt
Hizon Laboratories, Inc.Philippines
Trader: GX International, Inc.
DRP-16155
Jan 11, 2029
Rovasu 20Rosuvastatin (as calcium)
20 mg Film-Coated TabletAlu/Alu Blister Pack of 10's (Box of 30's)
RxVAT-exempt
Bafna Pharmaceuticals LimitedIndia
Emcure Pharma Philippines Inc.Importer: MedEthix, Inc
DRP-7993-03
Sep 27, 2028
RovecolRosuvastatin (as calcium)
20 mg Film Coated TabletAlu/Alu Blister Pack x 10's (Box of 30's)
RxVAT-exempt
Healer's Lab (Unit II)India
Teramedix Pharma Trading Inc.
DRP-15308
Jun 13, 2029
Rovex 10Rosuvastatin (As Calcium)
10 mg Film-Coated TabletAlu/Alu Blister Pack X 10's (Box of 30's)
RxVAT-exempt
Rhydburg Pharmaceuticals LtdIndia
VE Pharma Inc.Importer: Genedrift Philippines OPC
DRP-7037-02
Feb 10, 2031
Rovex 20Rosuvastatin (as calcium)
20 mg Film-Coated TabletAlu/Alu Blister Pack x 10’s (Box of 30’s)
RxVAT-exempt
Akums Drugs & Pharmaceuticals Ltd.India
VE Pharma Inc.Trader: Vexxa Lifesciences Pvt. Ltd
DR-XY44964
Jan 5, 2031
RovicorRosuvastatin (as Calcium)
10 mg Film-Coated TabletAlu-Alu Blister Pack x 10’s (Box of 30’s)
RxVAT-exempt
PSA Chemicals & Pharmaceuticals Pvt. Ltd.India
Diafarm Inc.Importer: Ambica International CorporationTrader: Rainbow Life Sciences Pvt. Ltd.
DRP-15849-05
Sep 23, 2029
RovistaRosuvastatin (as calcium)
10mg Film-Coated TabletAlu/Alu Blister Pack x 10's (Box of 10's and 30's)
RxVAT-exempt
Getz Pharma (Pvt.) Ltd.Pakistan
Importer: Getz Pharma (Phils.), Inc.
DR-XY35027
Jan 16, 2029
RovistaRosuvastatin (as calcium)
20mg Film-Coated TabletAlu/Alu Blister Pack x 10’s (Box of 10’s & 30's)
RxVAT-exempt
Getz Pharma (Pvt.) Ltd.Pakistan
Importer: Getz Pharma (Phils.), Inc.
DR-XY35026
Jan 16, 2029
RovistaRosuvastatin (as calcium)
5mg Film-Coated TabletAlu/Alu Blister Pack x 10's (Box of 10's and 30's)
RxVAT-exempt
Getz Pharma (Pvt.) Ltd.Pakistan
Importer: Getz Pharma (Phils.), Inc.
DR-XY35028
Jan 16, 2029
Roxunov 10Rosuvastatin (as calcium)
10 mg Film Coated Tablet
RxVAT-exempt
S Kant Healthcare Ltd.India
Medinova Pharmaceutical Inc.
DRP-17698
Feb 19, 2031
Roxunov 20Rosuvastatin (as calcium)
20 mg Film-Coated Tablet
RxVAT-exempt
S Kant Healthcare Ltd.India
Medinova Pharmaceutical Inc.
DRP-17697
Feb 19, 2031
Roxunov 40Rosuvastatin (as calcium)
40 mg Film-Coated Tablet
RxVAT-exempt
S Kant Healthcare Ltd.India
Medinova Pharmaceutical Inc.
DRP-17690
Feb 18, 2031
Rozatin- 40Rosuvastatin (As Calcium)
40mg Film-Coated TabletAlu/Alu Blister Pack x 10's (Box of 100's)
RxVAT-exempt
Fredun Pharmaceuticals LimitedIndia
AMB HK Enterprises, Inc.Importer: AMB HK Enterprises Inc.
DRP-12140
Jun 20, 2027
Rozatin- 5Rosuvastatin (as calcium)
5 mg Film-Coated TabletAlu/Alu Blister Pack x 10's (Box of 100's)
RxVAT-exempt
Fredun Pharmaceuticals LimitedIndia
AMB HK Enterprises, Inc.Importer: AMB HK Enterprises Inc.
DRP-12202
Jun 29, 2027
Rozatin-10Rosuvastatin (as calcium)
10 mg Film-Coated TabletAlu/Alu Blister Pack x 10's (Box of 30's and 100's)
RxVAT-exempt
Fredun Pharmaceuticals LimitedIndia
AMB HK Enterprises Inc.
DRP-12201
Jun 29, 2032
Rozatin-10Rosuvastatin (as calcium).
10 mg Film-Coated TabletAlu/Alu blister pack x 10's (Box of 100's)
RxVAT-exempt
Baroque Pharmaceuticals Pvt. Ltd.India
AMB HK Enterprises Inc.
DRP-16322
Jun 3, 2030
Rozatin-20Rosuvastatin (as calcium)
20 mg Film Coated TabletAlu/Alu blister pack x 10's (Box of 100's)
RxVAT-exempt
Baroque Pharmaceuticals Pvt. Ltd.India
AMB HK Enterprises Inc.
DRP-16323
Jun 3, 2030
Rozatin-20Rosuvastatin (as calcium)
20 mg Film-Coated TabletAlu/Alu Blister Pack x 10's (Box of 30's and 100's)
RxVAT-exempt
Fredun Pharmaceutical LimitedIndia
AMB HK ENTERPRISES, INC.
DRP-12200
Jun 29, 2032
Rozatin-40Rosuvastatin (as calcium)
40 mg Film Coated TabletAlu/Alu blister pack x 10's (Box of 100's)
RxVAT-exempt
Baroque Pharmaceuticals Pvt. Ltd.India
AMB HK Enterprises Inc.
DRP-16324
Jun 3, 2030
Rozatin-5Rosuvastatin (as calcium)
5 mg Film-Coated TabletAlu/Alu blister pack x 10's (Box of 100's)
RxVAT-exempt
Baroque Pharmaceuticals Pvt. Ltd.India
AMB HK Enterprises Inc.
DRP-16321
Jun 3, 2030
RoztatRosuvastatin
10 mg Film-coated TabletAlu/Alu Strip Foil x 10's (Box of 100's)
RxVAT-exempt
Aurochem Pharmaceutical (I) Pvt. Ltd.India
Endure Medical, Inc.
DR-XY44265
Mar 20, 2031
RoztatRosuvastatin (as calcium)
20 mg Film-Coated TabletAlu/Alu Foil Strip x 10's (Box of 100's)
RxVAT-exempt
Aurochem Pharmaceutical (I) Pvt. Ltd.India
Endure Medical, Inc.
DR-XY45279
Apr 14, 2031
Roztin-10Rosuvastatin (as calcium)
10 mg Film-Coated TabletAlu/Alu Blister Pack x 10's (Box of 30's)
RxVAT-exempt
Gracure Pharmaceutical Ltd.India
Aglobal Care, Inc.
DRP-16843
Jul 16, 2030
ROZTIN-20Rosuvastatin (as Calcium)
20 mg Film-Coated TabletAlu/Alu Blister Pack x 10's (Box of 30's)
RxVAT-exempt
GRACURE PHARMACEUTICAL LTD.India
AGLOBAL CARE, INC.
DRP-8482
Jan 15, 2029
ROZUGENRosuvastatin (as Calcium)
10 mg Film-coated TabletAlu/Alu Blister Pack x 10's (Box of 30's, 50's & 100's)
RxVAT-exempt
Azarias Pharmaceutical Laboratories Inc.Philippines
Eba Generisch Trading Inc.
DRP-16595-0
May 13, 2030
RozugenRosuvastatin (as calcium)
20 mg Film-Coated TabletAlu/Alu Blister Pack x 10's (Box of 30's, 50's and 100's)
RxVAT-exempt
Azarias Pharmaceutical Laboratories Inc.Philippines
Eba Generisch Trading Inc.
DRP-16586-06
May 8, 2030
RozugenRosuvastatin (as Calcium)
5 mg Film-coated TabletAlu/Alu Blister Pack x 10's (Box of 30's, 50's & 100's)
RxVAT-exempt
Azarias Pharmaceutical Laboratories Inc.Philippines
Eba Generisch Trading Inc.
DRP-16945-03
Sep 2, 2030
Rozuhil-10Rosuvastatin (as calcium)
10 mg Film-Coated TabletAlu/Alu Blister Pack x 10's (Box of 30's and 100's)
RxVAT-exempt
Gracure Pharmaceutical Ltd.India
Hillcross Prime, Inc.Importer: Sanimed Pharmaceuticals Inc.
DRP-14693-01
Nov 28, 2028
Rozuhil-20Rosuvastatin (as calcium)
20 mg Film-Coated TabletAlu/Alu Blister Pack x 10's (Box of 30's and 100's)
RxVAT-exempt
Gracure Pharmaceutical Ltd.India
Hillcross Prime, Inc.Importer: Sanimed Pharmaceuticals Inc.
DRP-14694-01
Nov 28, 2028
Rozusan-10Rosuvastatin (as calcium)
10 mg Film-Coated TabletAlu/Alu Blister Pack x 10's (Box of 30's)
RxVAT-exempt
Gracure Pharmaceutical Ltd.India
Sanimed Pharmaceuticals Inc.
DRP-14693
Nov 28, 2028
Rozusan-20Rosuvastatin (as calcium)
20 mg Film-Coated TabletAlu/Alu Blister Pack x 10's (Box of 30's)
RxVAT-exempt
Gracure Pharmaceutical Ltd.India
Sanimed Pharmaceuticals Inc.
DRP-14694
Nov 28, 2028
RozutorRosuvastatin (as calcium)
10 mg Film- Coated TabletAlu/Alu Blister Pack x 10's (Box of 30's)
RxVAT-exempt
Elpen Pharmaceutical Co., Inc.Greece
AJ Research & Pharma, Inc..Importer: AJ Research & Pharma
DR-XY47787
Mar 8, 2027
RozutorRosuvastatin (as calcium)
20 mg Film- Coated TabletsAlu/Alu Blister Pack x 10's (Box of 30's)
RxVAT-exempt
Elpen Pharmaceutical Co., Inc.Greece
AJ Research & Pharma, Inc..Importer: AJ Research & Pharma
DR-XY47786
Mar 8, 2027
Rozuvas 10Rosuvastatin (as calcium)
10 mg Film-Coated TabletAlu/Alu Blister Pack x 10's (Box of 30's and 100's)
RxVAT-exempt
Magbro Healthcare Pvt. Ltd.India
RoDaise Pharma Distributor CorporationImporter: Teramedix Pharma Trading Inc.
DRP-13727-03
Apr 4, 2028
RozzuRosuvastatin (as Calcium)
10 mg Film-coated TabletAlu/Alu Blister Pack x 10's (Box of 30's, 50's & 100's)
RxVAT-exempt
Azarias Pharmaceutical Laboratories Inc.,Philippines
—
DRP-16595
May 13, 2030
RozzuRosuvastatin (as calcium)
20 mg Film-Coated TabletAlu/Alu Blister Pack x 10's (Box of 30's, 50's and 100's)
RxVAT-exempt
Azarias Pharmaceutical Laboratories, Inc.Philippines
—
DRP-16586
May 8, 2030
RozzuRosuvastatin (as calcium)
5 mg Film-coated TabletAlu/Alu Blister Pack x 10's (Box of 30's, 50's & 100's)
RxVAT-exempt
Azarias Pharmaceutical Laboratories Inc.Philippines
—
DRP-16945
Sep 2, 2030
RucholRosuvastatin (as Calcium)
10 mg Film-Coated TabletAlu/Alu Blister Pack x 10's (Box of 30's and 100's) and (Box of 1's) as Physician's Sample
RxVAT-exempt
Pharmevo (Pvt) LimitedPakistan
Mirabell Medical Corp.Importer: Accesspoint International Trading Inc.
DRP-12702-08
May 11, 2030
RucholRosuvastatin (as calcium)
20 mg Film-Coated TabletAlu/Alu Blister Pack x 10 Tablets (Box of 30's)
RxVAT-exempt
Zim Laboratories LimitedIndia
Mirabell Medical Corp.Importer: Suhitas Pharmaceuticals Inc.Trader: Amegh Pharma Pvt. Ltd.
DRP-9786
Nov 27, 2028
RucholRosuvastatin (as calcium)
20 mg Film-Coated TabletAlu/Alu Blister Pack x 10's (Box of 30’s)
RxVAT-exempt
Zim Laboratories LimitedIndia
Mirabell Medical Corp.Importer: Orange Biotec Inc.Trader: Amegh Pharma Pvt. Ltd.
DRP-9786-01
Nov 27, 2028
RustorRosuvastatin (as Calcium)
10 mg Film-Coated TabletAlu/Alu Blister Pack x 10's (Box of 30's)
RxVAT-exempt
Lloyd Laboratories, Inc.Philippines
Trader: Innogen Pharmaceuticals, Inc.
DRP-8674
Jul 4, 2029
RustorRosuvastatin (as Calcium)
20 mg Film-Coated TabletIn a Box of 3 Alu/Alu Blister Pack x 10's
RxVAT-exempt
Lloyd Laboratories, Inc.Philippines
Trader: Innogen Pharmaceuticals, Inc.
DRP-7629
Dec 9, 2030
Ruvastin-10Rosuvastatin (as calcium)
10mg Film-Coated TabletAlu/Alu Blister pack x 10's (Box of 20's)
RxVAT-exempt
Aristopharma Ltd.Bangladesh
Sahar International Trading, Inc
DR-XY44850
Oct 2, 2030
Ruvastin-5Rosuvastatin (as calcium)
5mg Film-Coated TabletAlu/Alu Blister Pack of 10's (Box of 30's)
RxVAT-exempt
Aristopharma LtdBangladesh
Sahar International Trading, Inc.
DR-XY44774
Sep 2, 2030
SearosuRosuvastatin (as calcium)
10 mg Film-Coated TabletAlu/Alu Blister Pack x 10's (Box of 100's)
RxVAT-exempt
Magbro Healthcare Pvt. Ltd.India
SEA-King Pharma Inc.Importer: Pharmakon Biotec Inc.
DRP-14226-01
Oct 28, 2027
SorvaztinRosuvastatin Calcium
10 mg Film-Coated TabletAlu/Alu Blister Pack x 10's (Box of 30's)
RxVAT-exempt
Lloyd Laboratories, Inc.Philippines
Wecare Pharma Corp.Trader: Euro-Health Care Exponents, Inc.
DR-XY44498
Apr 27, 2031
SorvaztinRosuvastatin Calcium
20 mg Film-Coated TabletAlu/Alu Blister Pack x 10's (Box of 30's)
RxVAT-exempt
Lloyd Laboratories, Inc.Philippines
WeCare Pharma Corp.Trader: Euro-Health Care Exponents, Inc.
DRP-8108-01
Feb 11, 2030
Stachol 20Rosuvastatin (as calcium)
20 mg TabletAlu/Alu Blister Pack x 10's (Box of 30's and 100's)
RxVAT-exempt
Magbro Healthcare Pvt. Ltd.India
Pharma King DistributorImporter: Pharmakon Biotec Inc.
DRP-10077-11
Oct 6, 2030
StapharmRosuvastatin (as calcium)
10 mg Film-Coated TabletAlu/Alu Blister pack x 10's (Box of 100's)
RxVAT-exempt
Magbro Healthcare Pvt. Ltd.India
Pharmakon Biotec Inc.Importer: Teramedix Pharma Trading Inc.
DRP-13727-08
Apr 4, 2028
StatorRosuvastatin (as calcium)
10 mg Film-Coated TabletAlu/Alu blister pack x 10's (Box of 100’s)
RxVAT-exempt
Magbro Healthcare Pvt. Ltd.India
Mc Graw Pharma Inc.Importer: Pharmakon Biotec Inc.
DRP-14226-03
Oct 28, 2027
StatorRosuvastatin (as calcium)
20mg Film-Coated TabletAlu/Alu Blister Pack x 10's (Box of 30's)
RxVAT-exempt
Magbro Healthcare Pvt. Ltd.India
Mc Graw Pharma Inc.Importer: Pharmakon Biotec Inc.
DRP-10077-08
Oct 6, 2030
StatovexRosuvastatin (as Calcium)
10 mg Film-Coated TabletAlu-Alu Blister Pack x 10’s (Box of 30’s)
RxVAT-exempt
PSA Chemicals & Pharmaceuticals Pvt. Ltd.India
Ambitech Biopharmaceuticals Inc.Importer: Ambica International CorporationTrader: Rainbow Life Sciences Pvt. Ltd.
DRP-15849-04
Sep 23, 2029
StratorRosuvastatin (as calcium)
20 mg Film-Coated TabletAlu/Alu Blister Pack x 10's (Box of 30's)
RxVAT-exempt
Gracure Pharmaceutical Ltd.India
Despina Pharma Inc.
DRP-15767
Sep 12, 2029
StravasRosuvastatin (As Calcium)
5 mg Film-Coated TabletAlu Foil and Polyamide/Alu/PVC Blister Pack x 6's (Box of 30's)
RxVAT-exempt
Zhejiang Jingxin Pharmaceutical Co. Ltd.China
Hexagon Pharmaceuticals
DRP-13344
Jan 31, 2028
Stravas 10Rosuvastatin (As Calcium)
10 mg Film-Coated TabletAlu Foil and Polyamide/Alu/PVC Blister Pack x 6's (Box) of 30's)
RxVAT-exempt
Zhejiang Jingxin Pharmaceutical Co. Ltd.China
Hexagon Pharmaceuticals
DRP-13345
Jan 31, 2028
Suvast-20Rosuvastatin (as calcium)
20mg Film-Coated TabletAlu/Alu Blister Pack x 10's (Box of 30's)
RxVAT-exempt
Magbro Healthcare Pvt. Ltd.India
RL Pharma Enterprises Inc.Importer: Pharmakon Biotec Inc.
DRP-10077-07
Oct 6, 2030
SuvastinRosuvastatin (as Calcium)
10 mg Film-Coated TabletAlu/Alu Blister Pack x 10's (Box of 30's, 50's & 100's)
RxVAT-exempt
Azarias Pharmaceutical Laboratories Inc.Philippines
St. Raphael Archangel Pharmaceutical Product Distribution
DRP-16595-03
May 13, 2030
SuvastinRosuvastatin (as Calcium)
20 mg Film-Coated TabletAlu/Alu Blister Pack x 10's (Box of 30's, 50's and 100's)
RxVAT-exempt
Azarias Pharmaceutical Laboratories Inc.Philippines
St. Raphael Archangel Pharmaceutical Product Distribution
DRP-16586-05
May 8, 2030
SuvastinRosuvastatin (as Calcium)
5 mg Film-Coated TabletAlu/Alu Blister Pack x 10's (Box of 100's)
RxVAT-exempt
Azarias Pharmaceutical Laboratories, Inc.Philippines
St. Raphael Archangel Pharmaceutical Product Distribution
DRP-16945-02
Sep 2, 2030
TobistatinRosuvastatin (as Calcium)
10 mg TabletAluminum Foil Strip x 4's (Box of 100's)
RxVAT-exempt
Diamond Laboratories Inc.Philippines
Tobie Pharma, Inc.
DRP-7609-01
Jan 11, 2031
TobistatinRosuvastatin (as calcium)
5 mg TabletAluminum Foil Strip x 4's (Box of 100's)
RxVAT-exempt
Diamond Laboratories Inc.Philippines
Tobie Pharma, Inc.
DRP-7608-01
Aug 11, 2031
TorrosRosuvastatin Calcium
10 mg Film-Coated TabletAlu/Alu Blister Pack x 10's (Box of 30's)
RxVAT-exempt
Lloyd Laboratories, Inc.Philippines
Trader: Medhaus Pharma, Incorporated
DR-XY44195
Feb 11, 2030
TorrosRosuvastatin Calcium
20 mg Film-Coated TabletAlu/Alu Blister Pack x 10's (Box of 30's)
RxVAT-exempt
Lloyd Laboratories, Inc.Philippines
Trader: Medhaus Pharma, Incorporated
DR-XY44194
Feb 11, 2030
Torus-10Rosuvastatin (As Calcium)
10 mg Film-Coated TabletAlu/Alu Blister Pack x 10's (Box of 30's)
RxVAT-exempt
Torrent Pharmaceuticals Ltd.India
Torrent Pharma Philippines, Inc.
DRP-6581
May 9, 2029
Torus-20Rosuvastatin (As Calcium)
20 mg Film-Coated TabletAlu/Alu Blister Pack x 10's (Box of 30's)
RxVAT-exempt
TORRENT PHARMACEUTICALS, LTD.India
Importer: TORRENT PHARMA PHILIPPINES, INC.
DRP-6582
May 9, 2029
TriastinRosuvastatin (as calcium)
20 mg Film-Coated TabletLaminated Aluminum Foil Strip x 10's (Box of 100's)
RxVAT-exempt
Interphil Laboratories, Inc.Philippines
Trianon Diagnostics Inc.
DRP-13856-03
Jul 4, 2030
TrisovanRosuvastatin
40 mg Film-Coated TabletAlu-PVC/PE Blister pack x 10's (Box of 100's)
RxVAT-exempt
TITAN LABORATORIES PVT. LTD.India
Triple Tact Import & Export Corp.
DRP-18685
Aug 27, 2031
Turbovas -10Rosuvastatin ( as calcium )
10 mg Film Coated TabletAluminum Foil Strip x 10's (Box of 30's and 100's)
RxVAT-exempt
Micro Labs LimitedIndia
Brown & Burk Philippines Inc.
DRP-6487
Jan 25, 2028
TURBOVAS -5Rosuvastatin (as calcium)
5mg Film Coated TabletAlu/Alu Foil Strip x 10's [Box of 30's]
RxVAT-exempt
Micro Labs LimitedIndia
Brown & Burk Philippines Inc.
DR-XY 41586
Apr 22, 2031
Turbovas-20Rosuvastatin ( as calcium)
20 mg Film Coated TabletAlu/Alu blister Pack x 10's (Box of 3 blister packs x 10's and Box of 10 blister packs x 10's)
RxVAT-exempt
Micro Labs LimitedIndia
Brown & Burk Philippines Inc.
DR-XY43884
Nov 12, 2029
UnbrandedRosuvastatin
10 mg Film-Coated TabletAlu/Alu Blister Pack x 15's (Box of 30's)
RxVAT-exempt
IPR Pharmaceuticals, Inc.Puerto Rico
Philusa CorporationImporter: AstraZeneca Pharmaceuticals (Phils.), Inc.Trader: AstraZeneca UK Ltd.
DRP-8017-01
Aug 1, 2031
UnbrandedRosuvastatin
20 mg Film-Coated TabletAlu/Alu Blister Pack x 15's (Box of 30's)
RxVAT-exempt
IPR Pharmaceuticals, IncorporatedPuerto Rico
Philusa CorporationImporter: AstraZeneca Pharmaceuticals (Phils.), Inc.Trader: AstraZeneca UK Ltd.
DRP-8016-01
Aug 1, 2031
UnbrandedRosuvastatin (as Calcium)
5 mg Film-Coated TabletAlu/Alu Blister Pack x 10’s (Box of 10’s)
RxVAT-exempt
Maple Pharmaceuticals (Pvt) LimitedPakistan
Diafarm Inc.Importer: Ambica International Corporation
DRP-6651-01
Aug 19, 2037
VarostinRosuvastatin (as calcium)
10 mg Film Coated TabletAlu/Alu Blister Pack x 10's (Box of 30's)
RxVAT-exempt
Nucare Labs LLPIndia
ECE Pharmaceuticals Inc.Importer: Biophil Medical Equipment and Supplies Trading
DRP-16219
Jan 27, 2030
VarostinRosuvastatin (as calcium)
10 mg Film-Coated TabletAlu/Alu Blister Pack x 10's (Box of 3 blister pack x 10's); Alu/Alu Blister Pack of 10's (Box of 10 blister pack x 10's)
RxVAT-exempt
Sapphire Lifesciences Pvt. Ltd.India
ECE Pharmaceuticals, Inc.Importer: Nelpa Lifesciences, Inc.
DRP-11330-01
Mar 3, 2027
VarostinRosuvastatin
20 mg Film-Coated TabletAlu-Alu Blister Pack x 10's (Box of 30's)
RxVAT-exempt
Nucare Labs LLPIndia
ECE Pharmaceuticals, Inc.Importer: Biophil Medical Equipment and Supplies Trading
DRP-16139
Nov 12, 2029
VarostinRosuvastatin (as calcium)
40 mg Film-Coated TabletAlu/Alu Blister Pack x 10's (Box of 30's, 60's, 90's and 100's)
RxVAT-exempt
Nucare Labs LLPIndia
ECE Pharmaceuticals, Inc.Importer: Biophil Medical Equipment and Supplies Trading
DRP-17488
Jan 12, 2031
VarostinRosuvastatin (as calcium)
5 mg Film-Coated TabletAlu/Alu Blister Pack x 10's (Box of 30's and 100's)
RxVAT-exempt
Nucare Labs LLPIndia
ECE Pharmaceuticals, Inc.Importer: Biophil Medical Equipment and Supplies Trading
DRP-17489
Jan 12, 2031
VasitraRosuvastatin (as calcium)
10 mg Film-Coated TabletAlu/ Alu Blister Pack x 10's (Box of 30's)
RxVAT-exempt
Magbro Healthcare Pvt. Ltd.India
Lakeside Pharmaceuticals Phil., Inc.Importer: Teramedix Pharma Trading Inc.
DRP-13727-09
Apr 4, 2028
VasitraRosuvastatin (as calcium)
20mg TabletAlu-Alu blister Pack x 10's (Box of 30's)
RxVAT-exempt
Magbro Healthcare Pvt. Ltd.India
Lakeside Pharmaceuticals Phil.Importer: Teramedix Pharma Trading Inc.
DRP-9986-07
Jul 8, 2031
Vasticure-10Rosuvastatin (As Calcium)
10 mg Film-Coated TabletAlu/Alu Blister Pack x 10's (Box of 30's)
RxVAT-exempt
Gracure Pharmaceutical Ltd.India
Healol Pharma Corporation
DRP-11075
Jan 25, 2027
Vasticure-20Rosuvastatin (As Calcium)
20 mg Film-Coated TabletAlu-Alu Blister Pack x 10's (Box of 30's)
RxVAT-exempt
Gracure Pharmaceutical Ltd.India
Healol Pharma Corporation
DRP-11073
Jan 25, 2027
Vastoril 10Rosuvastatin (as calcium)
10 mg Film-Coated TabletAlu/Alu Blister Pack x 10's (Box of 100's); Alu/Alu Blister Pack x 10's (Box of 30's)
RxVAT-exempt
Magbro Healthcare Pvt. Ltd.India
Alpha Farmaceutico Corp.Importer: Teramedix Pharma Trading Inc.
DRP-13727-07
Apr 4, 2028
Vastoril 20Rosuvastatin (as calcium)
20 mg TabletAlu/Alu Blister Pack x 10's (Box of 30's and 100's)
RxVAT-exempt
Magbro Healthcare Pvt. Ltd.India
Alpha Farmaceutico Corp.Importer: Teramedix Pharma Trading Inc.
DRP-9986-06
Jul 8, 2031
Vastros-20Rosuvastatin (as calcium)
20mg Film-Coated TabletAlu/Alu Blister Pack x 10's (Box of 30's)
RxVAT-exempt
Magbro Healthcare Pvt. Ltd.India
Teramedix Pharma Trading Inc.Importer: NPharmakon Biotec Inc.
DRP-10077-03
Oct 6, 2030
VazcareRosuvastatin (as Calcium)
10 mg Film-Coated TabletAlu/Alu Blister Pack x 10's (Box of 10's); Alu/Alu Blister Pack x 10's (Box of 1's) as Physician's Sample)
RxVAT-exempt
PharmEvo (Pvt.) Ltd.Pakistan
Medcare PharmaceuticalsImporter: Accesspoint International Trading Inc.
DRP-12702-03
Mar 15, 2037
Vestflo-10Rosuvastatin (as calcium)
10mg Film-Coated TabletAlu/Alu Blister Pack x10's (Box of 100's)
RxVAT-exempt
Magbro Healthcare Pvt. Ltd.India
Teramedix Pharma Trading Inc.
DRP-13727
Apr 4, 2028
Vestflo-20Rosuvastatin (as calcium)
20 mg TabletAlu/Alu Blister pack x 10's (Box of 30's and 100's)
RxVAT-exempt
Magbro Healthcare Pvt. Ltd.India
Cyden Medicale Trading Inc.Importer: Teramedix Pharma Trading Inc.
DRP-9986
Jul 8, 2031
WilovastRosuvastatin (as calcium)
10 mg Film-Coated TabletAlu/Alu Blister Pack x 10's (Box of 30's and 100's)
RxVAT-exempt
Hizon Laboratories, Inc.Philippines
Willore Pharma Corporation
DRP-6743
Mar 30, 2030
X-PlendedRosuvastatin (as Calcium)
10 mg Film-Coated TabletAlu/Alu Blister Pack x 10's (Box of 10's, 30's and 100's) and (Box of 1's) as Physician's Sample
RxVAT-exempt
Pharmevo (Pvt) LimitedPakistan
Accesspoint International Trading Inc.
DRP-12702
Feb 9, 2037
ZenrosuRosuvastatin (as calcium)
10mg Film-Coated TabletAlu/Alu blister pack x 10's (Box of 30'S) (OPA-layer:ca 25 um, ALU-layer:ca 45-47 um, PVC layer:ca 100 um; OPA-layer:ca 25 um, ALU-layer:ca 45 47 um, PVC-layer ca 60 um and Al-layer:25 um, thermo lacquer:PVC; Al-layer:20 um, thermo-lacquer:PVC)
RxVAT-exempt
Zentiva, k.s.Czech Republic
Sanofi-Aventis Philippines, Inc.
DR-XY42079
Oct 6, 2027
ZenrosuRosuvastatin (as calcium)
20mg Film-Coated TabletAlu/Alu blister pack x 10's (Box of 30'S) (OPA-layer:ca 25 um, ALU-layer:ca 45-47 um, PVC layer:ca 100 um; OPA-layer:ca 25 um, ALU-layer:ca 45 47 um, PVC-layer:ca 60 um and Al-layer:25 um, thermo lacquer:PVC; Al-layer:20 um, thermo-lacquer:PVC)
RxVAT-exempt
Zentiva, k.s.Czech Republic
Sanofi-Aventis Philippines, Inc.
DR-XY42092
Oct 6, 2027
ZyrovaRosuvastatin (as Calcium)
10 mg Film-Coated TabletAlu/Alu Blister Pack x 10's Box of 100's; Alu/Alu Blister Pack x 10's Box of 10's (as Physician Sample)
RxVAT-exempt
Zydus Lifesciences LimitedIndia
Zydus Healthcare Philippines, Inc.
DRP-10291
Dec 19, 2028
ZyrovaRosuvastatin (as Calcium)
20 mg Film-Coated TabletAlu/Alu Blister Pack x 10's (Box of 100's)
RxVAT-exempt
Zydus Lifesciences LimitedIndia
Zydus Healthcare Philippines, Inc.
DRP-10290
Dec 19, 2028
ZyrovaRosuvastatin (as calcium)
40 mg Film-Coated TabletAlu/Alu Blister Pack x 10's (Box of 30's)
RxVAT-exempt
Umedica Laboratories Pvt. Ltd.India
Zydus Healthcare Philippines Inc.Importer: Suhitas Pharmaceuticals Inc.
DRP-9478-01
Oct 25, 2031
ZyrovaRosuvastatin (as Calcium)
5 mg Film-Coated TabletAlu/Alu Blister Pack x 10’s (Box of 10’s and 30’s)
RxVAT-exempt
Maple Pharmaceuticals (Pvt.) Ltd.Pakistan
Zydus Healthcare Philippines Inc.Importer: Ambica International Corporation
DRP-6651-03
Aug 1, 2037
(no brand name)Rosuvastatin (as calcium)
10 mg Film-Coated TabletAlu/Alu Blister Pack x 10's (Box of 30's)
RxVAT-exempt
United International Pharma Co. Ltd.Vietnam
RiteMed Phils., Inc.
DRP-11622
Apr 4, 2027
(no brand name)Rosuvastatin (as calcium)
10 mg Film-Coated TabletAlu/Alu Blister Pack x 10's (Box of 30's)
RxVAT-exempt
Lloyd Laboratories, Inc.Philippines
—
DRP-16418
Mar 11, 2030
(no brand name)Rosuvastatin (as calcium)
20 mg Film-Coated TabletAlu/Alu Blister Pack x 10's (Box of 30's)
RxVAT-exempt
United International Pharma Co., Ltd.Vietnam
RiteMED Phils., Inc.,
DRP-11621
Apr 4, 2027
(no brand name)Rosuvastatin (as calcium)
20 mg Film-Coated TabletAlu/Alu Blister Pack x 10's (Box of 30's)
RxVAT-exempt
Lloyd Laboratories, Inc.Philippines
—
DRP-16417
Mar 11, 2030
(no brand name)Rosuvastatin (as Calcium)
20 mg Film-Coated TabletAlu-Alu Blister Pack X 10's (Box of 30's)
RxVAT-exempt
Lek S.A.Poland
RiteMed Phils., Inc.Importer: Sandoz Philippines Corporation.
DRP-6489-01
Apr 25, 2030
(no brand name)Rosuvastatin (as calcium)
20mg Film-Coated TabletAlu/Alu blister pack x 10's (Box of 30's)
RxVAT-exempt
Centurion Laboratories Pvt. Ltd.India
Philgen Pharmaceuticals Inc.
DRP-13394
Feb 10, 2028
(no brand name)Rosuvastatin (as calcium)
40 mg Film-Coated TabletAlu/Alu Blister Pack x 10's (Box of 30's)
RxVAT-exempt
Centurion Laboratories Pvt. Ltd.India
Philgen Pharmaceuticals Inc.
DRP-13370
Feb 8, 2028
(no brand name)Rosuvastatin (as calcium)
40 mg Film-Coated TabletAlu/Alu Blister Pack x 10's (Box of 30's)
RxVAT-exempt
Lloyd Laboratories, Inc.Philippines
—
DRP-16416
Mar 11, 2030
(no brand name)Rosuvastatin (as calcium)
5 mg Film-Coated TabletAlu/Alu Blister Pack x 10's (Box of 30's)
RxVAT-exempt
Lloyd Laboratories, Inc.Philippines
—
DRP-16419
Mar 11, 2030

Source: FDA Philippines product registration database. "Valid until" is the registration validity date listed by the FDA; a past date may mean a renewal is pending. Package insert links point to files published by the FDA.

United States (label)

Dosage forms and strengths (US label) US FDA label

3 DOSAGE FORMS AND STRENGTHS CRESTOR tablets: • 5 mg of rosuvastatin: yellow, round, biconvex, coated tablets. Debossed “ZD4522” and “5” on one side of the tablet. • 10 mg of rosuvastatin: pink, round, biconvex, coated tablets. Debossed “ZD4522” and “10” on one side of the tablet. • 20 mg of rosuvastatin: pink, round, biconvex, coated tablets. Debossed “ZD4522” and “20” on one side of the tablet. • 40 mg of rosuvastatin: pink, oval, biconvex, coated tablets. Debossed “ZD4522” on one side and “40” on the other side of the tablet. Tablets: 5 mg, 10 mg, 20 mg, and 40 mg of rosuvastatin. (3)

Warnings/Precautions

Warnings and precautions (US label) US FDA label
  • • Myopathy and Rhabdomyolysis: Risk factors include age 65 years or greater, uncontrolled hypothyroidism, renal impairment, concomitant use with certain other drugs, and higher CRESTOR dosage. Asian patients may be at higher risk for myopathy. Discontinue CRESTOR if markedly elevated CK levels occur or myopathy is diagnosed or suspected. Temporarily discontinue CRESTOR in patients experiencing an acute or serious condition at high risk of developing renal failure secondary to rhabdomyolysis. Inform patients of the risk of myopathy and rhabdomyolysis when starting or increasing CRESTOR dosage. Instruct patients to promptly report unexplained muscle pain, tenderness, or weakness, particularly if accompanied by malaise or fever. (5.1)
  • • Immune-Mediated Necrotizing Myopathy (IMNM): Rare reports of IMNM, an autoimmune myopathy, have been reported with statin use. Discontinue CRESTOR if IMNM is suspected. (5.2)
  • • Hepatic Dysfunction: Increases in serum transaminases have occurred, some persistent. Rare reports of fatal and non-fatal hepatic failure have occurred. Consider testing liver enzymes before initiating therapy and as clinically indicated thereafter. If serious hepatic injury with clinical symptoms and/or hyperbilirubinemia or jaundice occurs, promptly discontinue CRESTOR. (5.3)
5.1 Myopathy and Rhabdomyolysis

5.1 Myopathy and Rhabdomyolysis CRESTOR may cause myopathy [muscle pain, tenderness, or weakness associated with elevated creatine kinase (CK)] and rhabdomyolysis. Acute kidney injury secondary to myoglobinuria and rare fatalities have occurred as a result of rhabdomyolysis with statins, including CRESTOR. Risk Factors for Myopathy Risk factors for myopathy include age 65 years or greater, uncontrolled hypothyroidism, renal impairment, concomitant use with certain other drugs (including other lipid-lowering therapies), and higher CRESTOR dosage.

Asian patients on CRESTOR may be at higher risk for myopathy [see Drug Interactions (7.1) and Use in Specific Populations (8.8)]. The myopathy risk is greater in patients taking CRESTOR 40 mg daily compared with lower CRESTOR dosages. Steps to Prevent or Reduce the Risk of Myopathy and Rhabdomyolysis CRESTOR dosage modifications are recommended for patients taking certain medications; concomitant use with certain other medications should be avoided [see Dosage and Administration (2.6), Drug Interactions (7.1)].

Discontinue CRESTOR if markedly elevated CK levels occur or if myopathy is either diagnosed or suspected. Muscle symptoms and CK elevations may resolve if CRESTOR is discontinued. Temporarily discontinue CRESTOR in patients experiencing an acute or serious condition at high risk of developing renal failure secondary to rhabdomyolysis (e.g., sepsis; shock; severe hypovolemia; major surgery; trauma; severe metabolic, endocrine, or electrolyte disorders; or uncontrolled epilepsy).

Inform patients of the risk of myopathy and rhabdomyolysis when starting or increasing the CRESTOR dosage. Instruct patients to promptly report any unexplained muscle pain, tenderness or weakness, particularly if accompanied by malaise or fever.

5.2 Immune-Mediated Necrotizing Myopathy

5.2 Immune-Mediated Necrotizing Myopathy There have been rare reports of immune-mediated necrotizing myopathy (IMNM), an autoimmune myopathy, associated with statin use, including reports of recurrence when the same or a different statin was administered. IMNM is characterized by proximal muscle weakness and elevated serum creatine kinase that persist despite discontinuation of statin treatment; positive anti-HMG CoA reductase antibody; muscle biopsy showing necrotizing myopathy; and improvement with immunosuppressive agents.

Additional neuromuscular and serologic testing may be necessary. Treatment with immunosuppressive agents may be required. Discontinue CRESTOR if IMNM is suspected.

5.3 Hepatic Dysfunction

5.3 Hepatic Dysfunction Increases in serum transaminases have been reported with use of CRESTOR [see Adverse Reactions (6.1)]. In most cases, these changes appeared soon after initiation, were transient, were not accompanied by symptoms, and resolved or improved on continued therapy or after a brief interruption in therapy.

In a pooled analysis of placebo-controlled trials, increases in serum transaminases to more than three times the ULN occurred in 1.1% of patients taking CRESTOR versus 0.5% of patients treated with placebo. Marked persistent increases of hepatic transaminases have also occurred with CRESTOR. There have been rare postmarketing reports of fatal and non-fatal hepatic failure in patients taking statins, including CRESTOR.

Patients who consume substantial quantities of alcohol and/or have a history of liver disease may be at increased risk for hepatic injury [see Use in Specific Populations (8.7)]. Consider liver enzyme testing before CRESTOR initiation and when clinically indicated thereafter. CRESTOR is contraindicated in patients with acute liver failure or decompensated cirrhosis [see Contraindications (4)].

If serious hepatic injury with clinical symptoms and/or hyperbilirubinemia or jaundice occurs, promptly discontinue CRESTOR.

5.4 Proteinuria and Hematuria

5.4 Proteinuria and Hematuria In the CRESTOR clinical trial program, dipstick-positive proteinuria and microscopic hematuria were observed among CRESTOR treated patients. These findings were more frequent in patients taking CRESTOR 40 mg, when compared to lower doses of CRESTOR or comparator statins, though it was generally transient and was not associated with worsening renal function.

Although the clinical significance of this finding is unknown, consider a dose reduction for patients on CRESTOR therapy with unexplained persistent proteinuria and/or hematuria during routine urinalysis testing.

5.5 Increases in HbA1c and Fasting Serum Glucose Levels

5.5 Increases in HbA1c and Fasting Serum Glucose Levels Increases in HbA1c and fasting serum glucose levels have been reported with statins, including CRESTOR. Based on clinical trial data with CRESTOR, in some instances these increases may exceed the threshold for the diagnosis of diabetes mellitus [see Adverse Reactions (6.1)].

Optimize lifestyle measures, including regular exercise, maintaining a healthy body weight, and making healthy food choices.

Drug interactions

Drug interactions (US label) US FDA label
  • See full prescribing information for details regarding concomitant use of CRESTOR with other drugs that increase the risk of myopathy and rhabdomyolysis. (7.1)
  • Aluminum and Magnesium Hydroxide Combination Antacids: Administer CRESTOR at least 2 hours before the antacid. (7.2)
  • Warfarin: Obtain INR prior to starting CRESTOR. Monitor INR frequently until stable upon initiation, dosage titration or discontinuation. (7.3)
7.1 Drug

7.1 Drug Interactions that Increase the Risk of Myopathy and Rhabdomyolysis with CRESTOR Rosuvastatin is a substrate of CYP2C9 and transporters (such as OATP1B1, BCRP). Rosuvastatin plasma levels can be significantly increased with concomitant administration of inhibitors of CYP2C9 and transporters. Table 5 includes a list of drugs that increase the risk of myopathy and rhabdomyolysis when used concomitantly with CRESTOR and instructions for preventing or managing them [see Warnings and Precautions (5.1) and Clinical Pharmacology (12.3)].

Table 5: Drug Interactions that Increase the Risk of Myopathy and Rhabdomyolysis with CRESTOR Sofosbuvir/velpatasvir/voxilaprevir or Ledipasvir/sofosbuvir Prevention or Management: Avoid concomitant use with CRESTOR. Mechanism and Clinical Effect(s): Rosuvastatin plasma levels were significantly increased with concomitant administration of many anti-viral drugs, which increases the risk of myopathy and rhabdomyolysis.

Gemfibrozil Prevention or Management: Avoid concomitant use of gemfibrozil with CRESTOR. If use is unavoidable, initiate CRESTOR at 5 mg once daily and do not exceed a dosage of CRESTOR 10 mg once daily. Mechanism and Clinical Effect(s): Gemfibrozil significantly increased rosuvastatin exposure and gemfibrozil may cause myopathy when given alone.

The risk of myopathy and rhabdomyolysis is increased with concomitant use. Tafamidis Prevention or Management: Avoid concomitant use of tafamidis with CRESTOR. If use is unavoidable, initiate CRESTOR at 5 mg once daily and do not exceed a dosage of CRESTOR 20 mg once daily. Monitor for signs of myopathy and rhabdomyolysis if used concomitantly with CRESTOR.

Mechanism and Clinical Effect(s): Tafamidis significantly increased rosuvastatin exposure and tafamidis may cause myopathy when given alone. The risk of myopathy and rhabdomyolysis is increased with concomitant use. Belumosudil Prevention or Management: In patients taking belumosudil, do not exceed a dosage of CRESTOR 5 mg once daily.

Mechanism and Clinical Effect(s): Belumosudil increased rosuvastatin exposure more than 4.6-fold. The risk of myopathy and rhabdomyolysis is increased with concomitant use. Cyclosporine Prevention or Management: In patients taking cyclosporine, do not exceed a dosage of CRESTOR 5 mg once daily. Mechanism and Clinical Effect(s): Cyclosporine increased rosuvastatin exposure 7-fold.

The risk of myopathy and rhabdomyolysis is increased with concomitant use. Darolutamide Prevention or Management: In patients taking darolutamide, do not exceed a dosage of CRESTOR 5 mg once daily. Mechanism and Clinical Effect(s): Darolutamide increased rosuvastatin exposure more than 5-fold. The risk of myopathy and rhabdomyolysis is increased with concomitant use.

Vadadustat Prevention or Management: In patients taking vadadustat, do not exceed a dosage of CRESTOR 5 mg once daily. Mechanism and Clinical Effect(s): Vadadustat increased rosuvastatin exposure by 2.5-fold. The risk of myopathy and rhabdomyolysis is increased with concomitant use. Additional Anti-Viral Medications Prevention or Management:

  • Simeprevir
  • Dasabuvir/ombitasvir/paritaprevir/ritonavir
  • Elbasvir/grazoprevir
  • Sofosbuvir/velpatasvir
  • Glecaprevir/pibrentasvir
  • Atazanavir/ritonavir
  • Lopinavir/ritonavir Initiate with CRESTOR 5 mg once daily, and do not exceed a dosage of CRESTOR 10 mg once daily. Mechanism and Clinical Effect(s): Rosuvastatin plasma levels were significantly increased with concomitant administration of many anti-viral drugs, which increases the risk of myopathy and rhabdomyolysis. Capmatinib Prevention or Management: In patients taking capmatinib, do not exceed a dosage of CRESTOR 10 mg once daily. Mechanism and Clinical Effect(s): Capmatinib increased rosuvastatin exposure more than 2.1-fold. The risk of myopathy and rhabdomyolysis is increased with concomitant use. Enasidenib Prevention or Management: In patients taking enasidenib, do not exceed a dosage of CRESTOR 10 mg once daily. Mechanism and Clinical Effect(s): Enasidenib increased rosuvastatin exposure more than 3.4-fold. The risk of myopathy and rhabdomyolysis is increased with concomitant use. Momelotinib Prevention or Management: In patients taking momelotinib, do not exceed a dosage of CRESTOR 10 mg once daily. Mechanism and Clinical Effect(s): Momelotinib increased rosuvastatin exposure by 2.7-fold. The risk of myopathy and rhabdomyolysis is increased with concomitant use. Regorafenib Prevention or Management: In patients taking regorafenib, do not exceed a dosage of CRESTOR 10 mg once daily. Mechanism and Clinical Effect(s): Regorafenib increased rosuvastatin exposure and may increase the risk of myopathy and rhabdomyolysis. Teriflunomide Prevention or Management: In patients taking teriflunomide, do not exceed a dosage of CRESTOR 10 mg once daily. Mechanism and Clinical Effect(s): Teriflunomide increased rosuvastatin exposure more than 2.5-fold. The risk of myopathy and rhabdomyolysis is increased with concomitant use. Ticagrelor Prevention or Management: In patients taking ticagrelor, do not exceed a dosage of CRESTOR 20 mg once daily. In patients at increased risk for rhabdomyolysis [see Warnings and Precautions (5.1)], consider dosages less than 20 mg per day. Mechanism and Clinical Effect(s): Ticagrelor increased rosuvastatin exposure by 2.3-fold. The risk of myopathy and rhabdomyolysis is increased with concomitant use. Febuxostat Prevention or Management: In patients taking febuxostat, do not exceed a dosage of CRESTOR 20 mg once daily. Mechanism and Clinical Effect(s): Febuxostat increased rosuvastatin exposure more than 1.9-fold. The risk of myopathy and rhabdomyolysis is increased with concomitant use. Fostamatinib Prevention or Management: In patients taking fostamatinib, do not exceed a dosage of CRESTOR 20 mg once daily. Mechanism and Clinical Effect(s): Fostamatinib increased rosuvastatin exposure more than 2.0-fold. The risk of myopathy and rhabdomyolysis is increased with concomitant use. Fenofibrates (e.g., fenofibrate and fenofibric acid) Prevention or Management: Consider if the benefit of using fibrates concomitantly with CRESTOR outweighs the increased risk of myopathy and rhabdomyolysis. If concomitant use is decided, monitor patients for signs and symptoms of myopathy, particularly during initiation of therapy and during upward dosage titration of either drug. Mechanism and Clinical Effect(s): Fibrates may cause myopathy when given alone. The risk of myopathy and rhabdomyolysis is increased with concomitant use. Colchicine Prevention or Management: Consider if the benefit of using colchicine concomitantly with CRESTOR outweighs the increased risk of myopathy and rhabdomyolysis. If concomitant use is decided, monitor patients for signs and symptoms of myopathy, particularly during initiation of therapy and during upward dosage titration of either drug. Mechanism and Clinical Effect(s): Cases of myopathy and rhabdomyolysis have been reported with concomitant use of colchicine with CRESTOR. Niacin Prevention or Management: Consider if the benefit of using lipid-modifying dosages (≥1 g/day) of niacin concomitantly with CRESTOR outweighs the increased risk of myopathy and rhabdomyolysis. If concomitant use is decided, monitor patients for signs and symptoms of myopathy, particularly during initiation of therapy and during upward dosage titration of either drug. Mechanism and Clinical Effect(s): Cases of myopathy and rhabdomyolysis have occurred with concomitant use of lipid-modifying dosages (≥1 g/day) of niacin with CRESTOR.
7.2 Drug

7.2 Drug Interactions that Decrease the Efficacy of CRESTOR Table 6 presents drug interactions that may decrease the efficacy of CRESTOR and instructions for preventing or managing them. Table 6: Drug Interactions that Decrease the Efficacy of CRESTOR Antacids Prevention or Management: In patients taking an antacid, administer CRESTOR at least 2 hours before the antacid.

Mechanism and Clinical Effect(s): Concomitant aluminum and magnesium hydroxide combination antacid administration decreased the mean exposure of rosuvastatin 50% [see Clinical Pharmacology (12.3)].

7.3 CRESTOR Effects on Other Drugs

7.3 CRESTOR Effects on Other Drugs Table 7 presents CRESTOR’s effect on other drugs and instructions for preventing or managing them. Table 7: CRESTOR Effects on Other Drugs Warfarin Prevention or Management: In patients taking warfarin, obtain an INR before starting CRESTOR and frequently enough after initiation, dosage titration or discontinuation to ensure that no significant alteration in INR occurs.

Once the INR is stable, monitor INR at regularly recommended intervals. Mechanism and Clinical Effect(s): Rosuvastatin significantly increased the INR in patients receiving warfarin [see Clinical Pharmacology (12.3)].

Metabolism and transporters (CYP, P-gp, OATP; US label) US FDA label

Rosuvastatin is a substrate for certain transporter proteins including the hepatic uptake transporter organic anion-transporting polyprotein 1B1 (OATP1B1) and efflux transporter breast cancer resistance protein (BCRP).

( 7.3 ) 7.1 Drug Interactions that Increase the Risk of Myopathy and Rhabdomyolysis with CRESTOR Rosuvastatin is a substrate of CYP2C9 and transporters (such as OATP1B1, BCRP).

Rosuvastatin plasma levels can be significantly increased with concomitant administration of inhibitors of CYP2C9 and transporters.

Adverse reactions

Adverse reactions (US label) US FDA label
  • The following important adverse reactions are described below and elsewhere in the labeling: Myopathy and Rhabdomyolysis [see Warnings and Precautions (5.1)] Immune-Mediated Necrotizing Myopathy [see Warnings and Precautions (5.2)] Hepatic Dysfunction [see Warnings and Precautions (5.3)] Proteinuria and Hematuria [see Warnings and Precautions (5.4)] Increases in HbA1c and Fasting Serum Glucose Levels [see Warnings and Precautions (5.5)] Most frequent adverse reactions (rate ≥2%) are headache, nausea, myalgia, asthenia, and constipation. (6.1)
  • To report SUSPECTED ADVERSE REACTIONS, contact AstraZeneca at 1-800-236-9933 or FDA at 1-800-FDA-1088 or www.fda.gov/medwatch.
6.1 Clinical Trials Experience

6.1 Clinical Trials Experience Because clinical trials are conducted under widely varying conditions, adverse reaction rates observed in the clinical trials of a drug cannot be directly compared to rates in the clinical trials of another drug and may not reflect the rates observed in clinical practice. Adverse reactions reported in ≥2% of patients in placebo-controlled clinical studies and at a rate greater than placebo are shown in Table 2.

These studies had a treatment duration of up to 12 weeks. Table 2: Adverse Reactions Reported in ≥2% of Patients Treated with CRESTOR and > Placebo in Placebo-Controlled Trials Adverse Reactions Placebo N=382 % CRESTOR 5 mg N=291 % CRESTOR 10 mg N=283 % CRESTOR 20 mg N=64 % CRESTOR 40 mg N=106 % Total CRESTOR 5 mg ‑ 40 mg N=744 % Headache 5.0 5.5 4.9 3.1 8.5 5.5 Nausea 3.1 3.8 3.5 6.3 0 3.4 Myalgia 1.3 3.1 2.1 6.3 1.9 2.8 Asthenia 2.6 2.4 3.2 4.7 0.9 2.7 Constipation 2.4 2.1 2.1 4.7 2.8 2.4 Other adverse reactions reported in clinical studies were abdominal pain, dizziness, hypersensitivity (including rash, pruritus, urticaria, and angioedema) and pancreatitis.

The following laboratory abnormalities have also been reported: dipstick-positive proteinuria and microscopic hematuria; elevated creatine phosphokinase, transaminases, glucose, glutamyl transpeptidase, alkaline phosphatase, and bilirubin; and thyroid function abnormalities. In the METEOR study, patients were treated with CRESTOR 40 mg (n=700) or placebo (n=281) with a mean treatment duration of 1.7 years.

Adverse reactions reported in ≥2% of patients and at a rate greater than placebo are shown in Table 3. Table 3: Adverse Reactions Reported in ≥2% of Patients Treated with CRESTOR and > Placebo in the METEOR Trial Adverse Reactions Placebo N=281 % CRESTOR 40 mg N=700 % Myalgia 12.1 12.7 Arthralgia 7.1 10.1 Headache 5.3

6.4 Dizziness 2

6.4 Dizziness 2.8 4.0 Increased CPK 0.7 2.6 Abdominal pain 1.8 2.4 ALT greater than 3x ULN Frequency recorded as abnormal laboratory value. 0.7 2.2 In the JUPITER study, patients were treated with CRESTOR 20 mg (n=8,901) or placebo (n=8,901) for a mean duration of 2 years. In JUPITER, there was a significantly higher frequency of diabetes mellitus reported in patients taking CRESTOR (2.8%) versus patients taking placebo (2.3%).

Mean HbA1c was significantly increased by 0.1% in CRESTOR-treated patients compared to placebo-treated patients. The number of patients with a HbA1c >6.5% at the end of the trial was significantly higher in CRESTOR-treated versus placebo-treated patients [see Clinical Studies (14)]. Adverse reactions reported in ≥2% of patients and at a rate greater than placebo are shown in Table 4.

Table 4: Adverse Reactions Reported in ≥2% of Patients Treated with CRESTOR and > Placebo in the JUPITER Trial Adverse Reactions Placebo N=8,901 % CRESTOR 20 mg N=8,901 % Myalgia 6.6 7.6 Arthralgia 3.2 3.8 Constipation 3.0 3.3 Diabetes mellitus 2.3 2.8 Nausea 2.3 2.4 Pediatric Patients with HeFH In a 12‑week controlled study in pediatric patients 10 to 17 years of age with HeFH with CRESTOR 5 mg to 20 mg daily [see Use in Specific Populations (8.4) and Clinical Studies (14)], elevations in serum CK greater than 10 x ULN were observed more frequently in CRESTOR-treated patients compared with patients receiving placebo. Four of 130 (3%) patients treated with CRESTOR (2 treated with 10 mg and 2 treated with 20 mg) had increased CK greater than 10 x ULN, compared to 0 of 46 patients on placebo.

6.2 Postmarketing Experience

6.2 Postmarketing Experience The following adverse reactions have been identified during postapproval use of CRESTOR. Because these reactions are reported voluntarily from a population of uncertain size, it is not always possible to reliably estimate their frequency or establish a causal relationship to drug exposure. Blood Disorders: thrombocytopenia Hepatobiliary Disorders: hepatitis, jaundice, fatal and non-fatal hepatic failure Musculoskeletal Disorders: arthralgia, rare reports of immune-mediated necrotizing myopathy associated with statin use Nervous System Disorders: peripheral neuropathy, rare postmarketing reports of cognitive impairment (e.g., memory loss, forgetfulness, amnesia, memory impairment, and confusion) associated with the use of all statins.

The reports are generally nonserious, and reversible upon statin discontinuation, with variable times to symptom onset (1 day to years) and symptom resolution (median of 3 weeks). There have been rare reports of new-onset or exacerbation of myasthenia gravis, including ocular myasthenia, and reports of recurrence when the same or a different statin was administered.

Psychiatric Disorders: depression, sleep disorders (including insomnia and nightmares) Reproductive System and Breast Disorders: gynecomastia Respiratory Disorders: interstitial lung disease Skin and Subcutaneous Tissue Disorders: drug reaction with eosinophilia and systemic symptoms (DRESS), lichenoid drug eruption

Adverse reaction frequency tables (US label) US FDA label
Table 2: Adverse Reactions Reported in ≥2% of Patients Treated with CRESTOR and > Placebo in Placebo-Controlled Trials
Adverse Reactions Placebo N=382 % CRESTOR 5 mg N=291 % CRESTOR 10 mg N=283 % CRESTOR 20 mg N=64 % CRESTOR 40 mg N=106 % Total CRESTOR 5 mg‑40 mg N=744 %
Headache 5.0 5.5 4.9 3.1 8.5 5.5
Nausea 3.1 3.8 3.5 6.3 0 3.4
Myalgia 1.3 3.1 2.1 6.3 1.9 2.8
Asthenia 2.6 2.4 3.2 4.7 0.9 2.7
Constipation 2.4 2.1 2.1 4.7 2.8 2.4
Table 3: Adverse Reactions Reported in ≥2% of Patients Treated with CRESTOR and > Placebo in the METEOR Trial
Adverse Reactions Placebo N=281 % CRESTOR 40 mg N=700 %
Myalgia 12.1 12.7
Arthralgia 7.1 10.1
Headache 5.3 6.4
Dizziness 2.8 4.0
Increased CPK 0.7 2.6
Abdominal pain 1.8 2.4
ALT greater than 3x ULNFrequency recorded as abnormal laboratory value. 0.7 2.2
Table 4: Adverse Reactions Reported in ≥2% of Patients Treated with CRESTOR and > Placebo in the JUPITER Trial
Adverse Reactions Placebo N=8,901 % CRESTOR 20 mg N=8,901 %
Myalgia 6.6 7.6
Arthralgia 3.2 3.8
Constipation 3.0 3.3
Diabetes mellitus 2.3 2.8
Nausea 2.3 2.4

Pregnancy considerations

Pregnancy (US label) US FDA label

8.1 Pregnancy Risk Summary Discontinue CRESTOR when pregnancy is recognized. Alternatively, consider the ongoing therapeutic needs of the individual patient. CRESTOR decreases synthesis of cholesterol and possibly other biologically active substances derived from cholesterol; therefore, CRESTOR may cause fetal harm when administered to pregnant patients based on the mechanism of action [see Clinical Pharmacology (12.1)].

In addition, treatment of hypercholesterolemia is not generally necessary during pregnancy. Atherosclerosis is a chronic process and the discontinuation of lipid-lowering drugs during pregnancy should have little impact on the outcome of long-term therapy of primary hypercholesterolemia for most patients. Available data from case series and prospective and retrospective observational cohort studies over decades of use with statins in pregnant women have not identified a drug-associated risk of major congenital malformations.

Published data from prospective and retrospective observational cohort studies with CRESTOR use in pregnant women are insufficient to determine if there is a drug-associated risk of miscarriage (see Data). In animal reproduction studies, no adverse developmental effects were observed in pregnant rats or rabbits orally administered rosuvastatin during the period of organogenesis at doses that resulted in systemic exposures equivalent to human exposures at the maximum recommended human dose (MRHD) of 40 mg/day, based on AUC and body surface area (mg/m2), respectively (see Data).

The estimated background risk of major birth defects and miscarriage for the indicated population is unknown. In the U.S. general population, the estimated background risk of major birth defects and miscarriage in clinically recognized pregnancies is 2 to 4% and 15 to 20%, respectively. Data Human Data A Medicaid cohort linkage study of 1,152 statin-exposed pregnant women compared to 886,996 controls did not find a significant teratogenic effect from maternal use of statins in the first trimester of pregnancy, after adjusting for potential confounders – including maternal age, diabetes mellitus, hypertension, obesity, and alcohol and tobacco use – using propensity score-based methods.

The relative risk of congenital malformations between the group with statin use and the group with no statin use in the first trimester was 1.07 (95% confidence interval 0.85 to 1.37) after controlling for confounders, particularly pre-existing diabetes mellitus. There were also no statistically significant increases in any of the organ-specific malformations assessed after accounting for confounders.

In the majority of pregnancies, statin treatment was initiated prior to pregnancy and was discontinued at some point in the first trimester when pregnancy was identified. Study limitations include reliance on physician coding to define the presence of a malformation, lack of control for certain confounders such as body mass index, use of prescription dispensing as verification for the use of a statin, and lack of information on non-live births.

Animal Data In female rats given 5, 15 and 50 mg/kg/day before mating and continuing through to gestation day 7 resulted in decreased fetal body weight (female pups) and delayed ossification at 50 mg/kg/day (10 times the human exposure at the MRHD of 40 mg/day based on AUC). In pregnant rats given 2, 10 and 50 mg/kg/day of rosuvastatin from gestation day 7 through lactation day 21 (weaning), decreased pup survival occurred at 50 mg/kg/day (dose equivalent to 12 times the MRHD of 40 mg/day based body surface area).

In pregnant rabbits given 0.3, 1, and 3 mg/kg/day of rosuvastatin from gestation day 6 to day 18, decreased fetal viability and maternal mortality was observed at 3 mg/kg/day (dose equivalent to the MRHD of 40 mg/day based on body surface area). Rosuvastatin crosses the placenta in rats and rabbits and is found in fetal tissue and amniotic fluid at 3% and 20%, respectively, of the maternal plasma concentration following a single 25 mg/kg oral gavage dose on gestation day 16 in rats.

In rabbits, fetal tissue distribution was 25% of maternal plasma concentration after a single oral gavage dose of 1 mg/kg on gestation day 18.

Mechanism of action

12.1 Mechanism of Action CRESTOR is an inhibitor of HMG‑CoA reductase, the rate-limiting enzyme that converts 3‑hydroxy‑3‑methylglutaryl coenzyme A to mevalonate, a precursor of cholesterol.

US FDA label

Pharmacodynamics

Pharmacodynamics (US label) US FDA label

12.2 Pharmacodynamics Inhibition of HMG-CoA reductase by rosuvastatin accelerates the expression of LDL-receptors, followed by the uptake of LDL-C from blood to the liver, leading to a decrease in plasma LDL-C and total cholesterol. Sustained inhibition of cholesterol synthesis in the liver also decreases levels of very-low-density lipoproteins. The maximum LDL-C reduction of CRESTOR is usually achieved by 4 weeks and is maintained after that.

Pharmacokinetics

Half-life and elimination (verbatim, US label)

Excretion Following oral administration, rosuvastatin and its metabolites are primarily excreted in the feces (90%).

The elimination half-life of rosuvastatin is approximately 19 hours.

Pharmacokinetics (US label) US FDA label

12.3 Pharmacokinetics Absorption In clinical pharmacology studies in man, peak plasma concentrations of rosuvastatin were reached 3 to 5 hours following oral dosing. Both C max and AUC increased in approximate proportion to CRESTOR dose. The absolute bioavailability of rosuvastatin is approximately 20%. The AUC of rosuvastatin does not differ following evening or morning drug administration.

Effect of food Administration of CRESTOR with food did not affect the AUC of rosuvastatin. Distribution Mean volume of distribution at steady-state of rosuvastatin is approximately 134 liters. Rosuvastatin is 88% bound to plasma proteins, mostly albumin. This binding is reversible and independent of plasma concentrations.

Elimination Metabolism Rosuvastatin is not extensively metabolized; approximately 10% of a radiolabeled dose is recovered as metabolite. The major metabolite is N-desmethyl rosuvastatin, which is formed principally by cytochrome P450 / 2C9, and in vitro studies have demonstrated that N-desmethyl rosuvastatin has approximately one-sixth to one-half the HMG‑CoA reductase inhibitory activity of the parent compound.

Overall, greater than 90% of active plasma HMG‑CoA reductase inhibitory activity is accounted for by the parent compound. Excretion Following oral administration, rosuvastatin and its metabolites are primarily excreted in the feces (90%). After an intravenous dose, approximately 28% of total body clearance was via the renal route, and 72% by the hepatic route.

The elimination half-life of rosuvastatin is approximately 19 hours. Specific Populations Geriatric Patients There were no differences in plasma concentrations of rosuvastatin between the nonelderly and elderly populations (age ≥65 years). Pediatric Patients In a population pharmacokinetic analysis of two pediatric trials involving patients with HeFH 10 to 17 years of age and 8 to 17 years of age, respectively, rosuvastatin exposure appeared comparable to or lower than rosuvastatin exposure in adult patients.

Male and Female Patients There were no differences in plasma concentrations of rosuvastatin between males and females. Racial or Ethnic Groups A population pharmacokinetic analysis revealed no clinically relevant differences in pharmacokinetics among White, Hispanic or Latino ethnicity, and Black or Afro-Caribbean groups.

However, pharmacokinetic studies, including one conducted in the US, have demonstrated an approximate 2-fold elevation in median exposure (AUC and Cmax) in Asian subjects when compared with a White control group. Patients with Renal Impairment Mild to moderate renal impairment (CLcr ≥30 mL/min/1.73 m2) had no influence on plasma concentrations of rosuvastatin.

However, plasma concentrations of rosuvastatin increased to a clinically significant extent (about 3‑fold) in patients with severe renal impairment (CLcr <30 mL/min/1.73 m2) not receiving hemodialysis compared with healthy subjects (CLcr >80 mL/min/1.73 m2). Steady-state plasma concentrations of rosuvastatin in patients on chronic hemodialysis were approximately 50% greater compared with healthy volunteer subjects with normal renal function.

Patients with Hepatic Impairment In patients with chronic alcohol liver disease, plasma concentrations of rosuvastatin were modestly increased. In patients with Child‑Pugh A disease, C max and AUC were increased by 60% and 5%, respectively, as compared with patients with normal liver function. In patients with Child‑Pugh B disease, C max and AUC were increased 100% and 21%, respectively, compared with patients with normal liver function.

Drug Interaction Studies Rosuvastatin clearance is not dependent on metabolism by cytochrome P450 3A4 to a clinically significant extent. Rosuvastatin is a substrate for certain transporter proteins including the hepatic uptake transporter organic anion-transporting polyprotein 1B1 (OATP1B1) and efflux transporter breast cancer resistance protein (BCRP).

Concomitant administration of CRESTOR with medications that are inhibitors of these transporter proteins (e.g., cyclosporine, certain HIV protease inhibitors [see Dosage and Administration (2.6) and Drug Interactions (7.1)] and ticagrelor [see Drug Interactions (7.1)]) may result in increased rosuvastatin plasma concentrations. Table 8: Effect of Coadministered Drugs on Rosuvastatin Systemic Exposure Coadministered drug and dosing regimen Rosuvastatin Mean Ratio (ratio with/without coadministered drug) No Effect=1.0 Dosage (mg) Single dose unless otherwise noted.

Change in AUC Change in C max Sofosbuvir/velpatasvir/voxilaprevir (400 mg/100 mg/100 mg) + Voxilaprevir (100 mg) once daily for 15 days 10 mg, single dose 7.39 Clinically significant [see Dosage and Administration (2) and Warnings and Precautions (5)] (6.68 to 8.18) Mean ratio with 90% CI (with/without coadministered drug, e.g., 1= no change, 0.7 = 30% decrease, 11=11-fold increase in exposure) 18.88 (16.23 to 21.96) Cyclosporine – stable dose required (75 mg – 200 mg BID) 10 mg, QD for 10 days 7.1 11 Darolutamide 600 mg BID, 5 days 5 mg, single dose 5.2 ~5 Belumosudil 200 mg QD, 8 days 10 mg, single dose on 2 separate days 4.62 3.59 Regorafenib 160 mg QD, 14 days 5 mg, single dose 3.8 4.6 Enasidenib 100 mg QD, 28 days 10 mg, single dose 3.4 4.66 Atazanavir/ritonavir combination 300 mg/100 mg QD for 8 days 10 mg 3.1 7 Simeprevir 150 mg QD, 7 days 10 mg, single dose 2.8 (2.3 to 3.4) 3.2 (2.6 to 3.9) Momelotinib 200 mg OD, 5 days 10 mg, single dose 2.7 3.2 Velpatasvir 100 mg once daily 10 mg, single dose 2.69 (2.46 to 2.94) 2.61 (2.32 to 2.92) Ombitasvir 25 mg/paritaprevir 150 mg/ ritonavir 100 mg + dasabuvir 400 mg BID 5 mg, single dose 2.59 (2.09 to 3.21) 7.13 (5.11 to 9.96) Teriflunomide Not available 2.51 2.65 Vadadustat 600 mg OD, 8 days 20 mg, single dose on 2 separate days 2.47 2.75 Ticagrelor 90 mg BID 10 mg, single dose 20 mg, single dose 2.3 2.3 2.4 2.6 Elbasvir 50 mg/grazoprevir 200 mg once daily 10 mg, single dose 2.26 (1.89 to 2.69) 5.49 (4.29 to 7.04) Glecaprevir 400 mg/pibrentasvir 120 mg once daily 5 mg, once daily 2.15 (1.88 to 2.46) 5.62 (4.80 to 6.59) Lopinavir/ritonavir combination 400 mg/100 mg BID for 17 days 20 mg, QD for 7 days 2.1 (1.7 to 2.6) 5 (3.4 to 6.4) Capmatinib 400 mg BID 10 mg, single dose 2.08 (1.56 to 2.76) 3.04 (2.36 to 3.92) Fostamatinib 100 mg BID 20 mg, single dose 1.96 (1.77 to 2.15) 1.88 (1.69 to 2.09) Febuxostat 120 mg QD for 4 days 10 mg, single dose 1.9 (1.5 to 2.5) 2.1 (1.8 to 2.6) Gemfibrozil 600 mg BID for 7 days 80 mg 1.9 to 2.2 to Tafamidis 61 mg BID on Days 1 & 2, followed by QD on Days 3 to 9 10 mg 1.97 (1.68 to 2.31) 1.86 (1.59 to 2.16) Eltrombopag 75 mg QD, 5 days 10 mg 1.6 (1.4 to 1.7) 2 (1.8 to 2.3) Darunavir 600 mg/ritonavir 100 mg BID, 7 days 10 mg, QD for 7 days 1.5 (1.0 to 2.1) 2.4 (1.6 to 3.6) Tipranavir/ritonavir combination 500 mg/200 mg BID for 11 days 10 mg 1.4 (1.2 to 1.6) 2.2 (1.8 to 2.7) Dronedarone 400 mg BID 10 mg 1.4 Itraconazole 200 mg QD, 5 days 10 mg or 80 mg 1.4 (1.2 to 1.6) 1.3 (1.1 to 1.4) 1.4 (1.2 to 1.5) 1.2 (0.9 to 1.4) Ezetimibe 10 mg QD, 14 days 10 mg, QD for 14 days 1.2 (0.9 to 1.6) 1.2 (0.8 to 1.6) Fosamprenavir/ritonavir 700 mg/100 mg BID for 7 days 10 mg 1.1 1.5 Fenofibrate 67 mg TID for 7 days 10 mg ↔ 1.2 (1.1 to 1.3) Rifampicin 450 mg QD, 7 days 20 mg ↔ Aluminum & magnesium hydroxide combination antacid Administered simultaneously Administered 2 hours apart 40 mg 40 mg 0.5 (0.4 to 0.5) 0.8 (0.7 to 0.9) 0.5 (0.4 to 0.6) 0.8 (0.7 to 1.0) Ketoconazole 200 mg BID for 7 days 80 mg 1.0 (0.8 to 1.2) 1.0 (0.7 to 1.3) Fluconazole 200 mg QD for 11 days 80 mg 1.1 (1.0 to 1.3) 1.1 (0.9 to 1.4) Erythromycin 500 mg QID for 7 days 80 mg 0.8 (0.7 to 0.9) 0.7 (0.5 to 0.9) QD/OD= Once daily, BID= Twice daily, TID= Three times daily, QID= Four times daily Table 9: Effect of Rosuvastatin Coadministration on Systemic Exposure to Other Drugs Rosuvastatin Dosage Regimen Coadministered Drug Mean Ratio (ratio with/without coadministered drug) No Effect=1.0 Name and Dosage Change in AUC Change in C max 40 mg QD for 10 days Warfarin Clinically significant pharmacodynamic effects [see Drug Interactions (7.3)] 25 mg single dose R- Warfarin 1.0 (1.0 to 1.1) Mean ratio with 90% CI (with/without coadministered drug, e.g., 1= no change, 0.7=30% decrease, 11=11-fold increase in exposure) S-Warfarin 1.1 (1.0 to 1.1) R-Warfarin 1.0 (0.9 to 1.0) S-Warfarin 1.0 (0.9 to 1.1) 40 mg QD for 12 days Digoxin 0.5 mg single dose 1.0 (0.9 to 1.2) 1.0 (0.9 to 1.2) 40 mg QD for 28 days Oral Contraceptive (ethinyl estradiol 0.035 mg & norgestrel 0.180, 0.215 and 0.250 mg) QD for 21 Days EE 1.3 (1.2 to 1.3) NG 1.3 (1.3 to 1.4) EE 1.3 (1.2 to 1.3) NG 1.2 (1.1 to 1.3) EE = ethinyl estradiol, NG = norgestrel, QD= Once daily

Formulary and pricing (Philippines)

Government price references

PreparationPrice (PHP)UnitType
Rosuvastatin (as Calcium) 10 mg Tablet₱2.44–₱8.93Reference ₱4.03per tabletDPRI procurement range
Rosuvastatin (as Calcium) 20 mg Tablet₱2.90–₱14.86Reference ₱6.48per tabletDPRI procurement range
10 mg (as calcium) tablet₱16.25per tabletPhilHealth GAMOT fixed fee
20 mg (as calcium) tablet₱23.25per tabletPhilHealth GAMOT fixed fee

PhilHealth GAMOT fixed fee paid to the accredited GAMOT pharmacy per unit dispensed Range = lowest-highest procurement price (highest usable only in GIDA areas); reference_price = 2021 DPRI ceiling (median)

These are government procurement and reimbursement references, not retail prices. Sources:

Formulary and coverage

Philippine National FormularyListed as Rosuvastatin (as calcium salt)
PNF listingOral: 10 mg and 20 mg tablet
PhilHealth GAMOTYes (listed since July 28, 2025)

Sources:

Check availability

Prices and stock vary by branch; renalcarematters.com does not sell medicines or receive payment from pharmacies.

References

  1. U.S. Food and Drug Administration. Crestor · AstraZeneca Pharmaceuticals LP [US FDA-approved label, version 19, September 23, 2026]. Via DailyMed/openFDA. https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=325a5d0e-9a72-4015-9fcd-1655fb504cee
  2. Food and Drug Administration Philippines. Verification portal (product registrations). https://verification.fda.gov.ph
  3. PNF Essential Medicines List, 8th ed. (as of November 2, 2022), DOH; https://www.philhealth.gov.ph/partners/providers/pdf/PNF-EML_11022022.pdf
  4. PhilHealth Circular No. 2026-0018, Expanding Access to Outpatient First-line Anti-TB Drugs through PhilHealth GAMOT, Annex A.i GAMOT List (81 molecules); https://www.philhealth.gov.ph/circulars/2026/PC-2026-0018.pdf
  5. PhilHealth Circular No. 2026-0018, Annex A.2 GAMOT Fixed Fee Schedule (249 preparations; fees otherwise unchanged from PC2025-0013); https://www.philhealth.gov.ph/circulars/2026/PC-2026-0018.pdf
  6. DOH Drug Price Reference Index (DPRI) 2021, 9th edition (as of September 17, 2021); https://caro.doh.gov.ph/wp-content/uploads/2021/09/2021DPRI-as-of-9-17-2021.pdf

This page shows official label and registry text only; no renalcarematters.com clinical summary has been approved for it yet.

For health professionals. This page is a reference compiled from public regulatory sources for licensed health professionals in the Philippines. Verify every product detail against the current Philippine package insert and the FDA Philippines registration record. Information here is not a substitute for clinical judgment and does not replace the prescribing information approved for the specific product you dispense or prescribe.

Last updated: .